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Abstract
Camel milk has been used for its nutritional and therapeutic benefits since ancient
times. Previously, whole camel milk and casein proteins have been explored for their
potential bioactive properties. However, studies on camel milk whey proteins and their
hydrolysates are still scarce. Hence, the aim of the proposed thesis was to evaluate
camel whey proteins and their hydrolysates for potential bioactivities like antioxidant,
antimicrobial,

antidiabetic, antihypertensive,

and anti-cholesterol

properties.

Production of the hydrolysates was carried out using three digestive enzymes – pepsin,
trypsin and chymotrypsin for 3 and 6 h of hydrolysis time. Hydrolysates were
characterized by degree of hydrolysis (DH) and reversed-phase high-performance
liquid chromatography (RP-HPLC). In vitro experiments were performed to evaluate
the bioactive properties of different camel whey protein hydrolysates (CWPHs).
Results revealed that CWPHs showed DH ranging from 11 to 47.5%, with
chymotrypsin (6 h) and trypsin (3 h) exhibiting highest and lowest DH, respectively.
RP-HPLC analysis revealed that α-lactalbumin underwent complete degradation and
newer shorter peptides were generated. Chymotrypsin generated CWPHs
demonstrated highest 2,2-diphenyl-1-picrylhydrazy (DPPH) and 2,2'-azino-bis (3ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scavenging activities, while
trypsin generated CWPHs displayed highest metal chelating activity. CWPHs showed
markedly greater antimicrobial activity than unhydrolyzed whey against all pathogenic
bacteria tested. Anti-cholesterol property via inhibition of cholesterol esterase and
lipase, and antihypertensive property via angiotensin-converting enzyme (ACE)
inhibition were found to be highest in pepsin (6 h) and (3 h) generated CWPHs,
respectively. CWPHs also displayed potential antidiabetic activity compared to intact
whey proteins, where pepsin and chymotrypsin generated CWPHs showed higher
inhibition of dipeptidyl peptidase-IV (DPP-IV), α-glucosidase and α-amylase (P <
0.05). Overall, CWPHs exhibited improved antioxidant, antimicrobial, and
antidiabetic properties as well as ACE, cholesterol esterase, and lipase inhibitory
effects compared to intact whey proteins in the in vitro conditions. Therefore, CWPHs
could be targeted for utilization as bioactive ingredient in functional foods and
nutraceuticals.
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)Title and Abstract (in Arabic

وصف الخصائص البيولوجية لمتحلالت بروتينات مصل حليب النوق التي انتجت من
معاملة بروتينات المعدة واالمعاء الدقيقة
الملخص

تم استخدام حليب اإلبل لفوائده الغذائية والعالجية منذ العصور القديمة .في السابق ،تم
استكشاف حليب اإلبل الكامل وبروتينات الكازيين لخصائصهما الحيوية النشطة .ومع ذلك ،ال
تزال الدراسات حول بروتينات مصل اللبن في حليب اإلبل وتحلالتها نادرة .ومن هنا ،كان الهدف
من الرسالة المقترحة هو تقييم بروتينات مصل حليب النوق وتحلالتها المائية من أجل نشاطاتها
الحيوية المحتملة كمضادات األكسدة ،ومضادات الميكروبات ،ومضادات السكر ،وخافضات
ضغط الدم ،وخواص ازالة الكولسترول .تم إجراء إنتاج متحلالت البروتين من بروتينات مصل
حليب النوق باستخدام ثالثة إنزيمات هضمية  -البيبسين  ،التريبسين والكيميوتريبسين لمدة  3و 6
ساعات .تم تقييم المتحلالت البروتينية بدرجة التحلل ) (DHوالكروماتوغرافيا السائلة عالية األداء
(. )RP-HPLCوأجريت التجارب المختبرية لتقييم الخصائص البيولوجية لمتحلالت البروتين
مصل الحليب النوق المختلفة .أظهرت بروتينات مصل حليب النوق ان نسب التحلل تتراوح من
 11إلى  ، ٪ 47.5مع الكيميوتريبسين ( 6ساعات) والتربسين ( 3ساعات) والتي تظهر أعلى
وأدنى نسبة تحلل بروتيني ،على التوالي .كشف تحليل والكروماتوغرافيا السائلة عالية األداء أن
بروتين الفا-الكتوالبومين خضع لعملية تحلل كاملة وأُنتجت ببتيدات أقصر .متحلالت البروتين
التي تولد من فعل الكيموتريبسين أظهر أعلى ( )DPPHو ( )ABTSكمضادات لألكسدة ،في
حين متحلالت البروتين الناتجة من معاملة انزيم التربسين انتجت معدل أعلى من مضاد االكسدة.
وأظهرت متحلالت البروتين نشاط مضاد للميكروبات أكبر بشكل ملحوظ من مصل اللبن غير
معامل ضد جميع البكتيريا المسببة لألمراض التي تم اختبارها.
مفاهيم البحث الرئيسية :حليب اإلبل ،بروتين مصل اللبن ،التحلل ،مضاد للضغط ،استريز
الكوليسترول
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Chapter 1: Introduction
1.1 Overview
Camel milk, in its fresh or fermented form, is considered an important part of
staple diet in many parts of the world, particularly in the arid and semi-arid zones (ElAgamy, 2007). Camels are categorized into two species: Camelus dromedarius (onehumped camel) and Camelus bactrianus (two-humped camel). The one-humped
camels live in the hot, arid regions in Africa, Middle-East and Africa, while the twohumped camels are mostly found in cold and arid areas of China, Kazakhstan, and
Mongolia (El-Agamy, 2007). Traditionally, camel milk has been used for treatment of
diseases like tuberculosis, asthma, dropsy, and jaundice (Abdelgadir et al., 1998).
Also, camel milk is said to have better digestibility and nutritional value than bovine
milk, making it one of the alternatives sources for human consumption (Salami et al.,
2009). There are some important differences between camel and bovine milk proteins.
For instance, camel milk lacks β-lactoglobulin (β-LG), a major protein in bovine milk
that can trigger allergic reactions. Moreover, camel whey protein has higher contents
of antimicrobial agents than bovine whey like lactoferrin, lysozyme, immunoglobulin,
and lactoperoxidase (Ahamad et al., 2017). These differences in proteins of camel
milk might display variable biological activities upon hydrolysis. Camel whey proteins
with different biological activities such as mineral-binding properties and
immunoglobulins have been reported (Farah & Atkins, 1992; Merin et al., 2001).
Peptides from dietary proteins have been extensively studied to investigate the
health effects they may show in humans like antioxidant activity, mineral binding,
reduction in blood pressure, immunomodulatory function and protective effects
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against various bacteria and viruses (Salami et al., 2010). Such peptides from milk
proteins are widely acknowledged (Kitts & Weiler, 2003). Indigenous protease
enzymes like milk plasmin, can hydrolyze proteins and liberate bioactive peptide
fragments during storage or processing (Mohanty et al., 2016). Bioactive peptides can
also be obtained via enzymatic hydrolysis with microbial and digestive enzymes
(Korhonen & Pihlanto, 2003). The activity of peptides is based on their inherent amino
acid composition and sequence (Meisel & Fitzgerald, 2003). Because camel milk has
different protein and amino acid profiles, it may be a good source of bioactive peptides
that might display variable biological activities (Khalesi et al., 2017)
The health-related bioactive properties of camel milk protein hydrolysates have
recently been reported (Salami et al., 2010, 2011; Kumar et al., 2016a, 2016b;
Nongonierma et al., 2017b, 2018). These hydrolysates were obtained via enzymatic
hydrolysis of camel milk proteins, which are susceptible to proteolysis (Salami et al.,
2011). Enzymatic hydrolysis is known to improve the functional properties of milk
proteins in addition to enhancement of the bioactive properties (Jrad, 2014). However,
camel milk proteins in their intact form have demonstrated bioactive properties like
anti-cancer, anti-hypertensive, hypo-allergic, and anti-diabetic (Konuspayeva et al.,
2009). Most of these properties of intact camel milk proteins have been demonstrated
in the in-vivo (human or rat model) systems. Since enzymatic hydrolysis can enhance
the bioactive properties of milk proteins, recent research is being focused on
generating bioactive hydrolysates from camel milk proteins and exploring their
potential bioactive properties in the in vitro as well as in vivo conditions (Mudgil et
al., 2018).

3
1.2 Statement of the Problem
In the UAE, camel milk production has increased to 42,400 tonnes, following
the growth in camel heads from 219713 to 412000 over the past decade (Mirzaei,
2012). The augmentation is not just limited to increase in camel milk production, but
several research attempts have been carried out, focusing on the health benefits of the
whole camel milk itself. Peptides derived from the milk of goat, sheep, and buffalo
exert multifunctional properties, including anti-microbial, immune modulatory, antioxidant, inhibitory effect on enzymes, anti-thrombotic, and antagonistic activities
against various toxic agents (Konuspayeva et al., 2009). During recent years, major
bovine whey protein components, α-LA and β-LG, have also been shown to contain
bioactive peptide sequences. Peptides showing opioid and angiotensin-converting
enzyme (ACE) inhibitory activity were found in bovine α-LA and β-LG (Solieri et al.,
2015). With diverse and extensive reports on milk derived bioactive peptides, research
focus is intensively being paid on the exploration of newer source of milk bioactive
peptides. In the recent years, the research activities on camel milk protein hydrolysates
has started taking pace. Considerable amount of work has been reported recently on
whole camel milk protein hydrolysate, however, studies exploring camel whey
proteins and their hydrolysates are still deficient. Camel whey protein hydrolysates
were previously demonstrated to possess antioxidant and antimicrobial properties
(Salami et al., 2010). To the best of our knowledge, there is no study being conducted
on investigating the antidiabetic properties (DPP-IV, α-amylase, α-glucosidase), lipase
and cholesterol esterase inhibiting properties of camel whey protein hydrolysates.
Also, data available on in-depth exploration of antioxidant and antimicrobial
properties of camel whey protein hydrolysates is limited. Thus, the present study has
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three main objectives – (i) to produce protein hydrolysates from camel milk whey
using different enzymes, and time of hydrolysis, (ii) to characterize the whey protein
hydrolysate using degree of hydrolysis and reversed-phase high performance liquid
chromatography (RP-HPLC), and (iii) to evaluate the whey protein hydrolysates
for various bioactivities including antioxidant, antimicrobial, antihypertensive,
antidiabetic and anti-cholesterol effects. The findings of this study can be exploited in
the development of foods with special health claims (e.g. treatment of hypertension,
diabetes, etc.) as well as in identifying new applications for camel milk derived
bioactive peptides.
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Chapter 2: Relevant Literature
Milk is a commodity consumed by millions of people around the world. Its
nutritional benefits are several, one of which is the growth and development of bones
in young children, due to milk being a good source of calcium and vitamin D. It has
also proven to be beneficial for older people, especially in menopausal women where
calcium deficiency is a high-risk factor for the development of osteoporosis. Milk is
not only a source of nutrition, but its production also contributes to food security and
income for most people in the developing countries. Around 150 million households
are engaged in milk production across the globe (FAO, 2012). It is particularly
beneficial for small scale producers because of quick cash turnouts.
One of the non-bovine sources which provides the required human nutrition
and offers therapeutic benefits is camel milk (Bai & Zhao, 2015). Camel milk yield
varies with breed, species, feeding conditions, and stage of lactation (Khaskheli et al.,
2005). Camel milk is white opaque, with a slightly salty taste. The pH of camel milk
ranges from 6.2 to 6.5 which is lower than that of bovine milk (6.5 to 6.7) (El-Hatmi
et al., 2015). The fat content in camel milk is very low, having 96% triglycerides
(Ereifej et al., 2011) and about 30 mg/100 g dry matter of cholesterol (Salwa & Lina,
2010). Camel milk’s fat has less short chain fatty acids in comparison to bovine milk
(Ereifej et al., 2011). Furthermore, the fat globules’ average size is smaller compared
to bovine, buffalo, and goat milk fat globules (Khalesi et al., 2017). Although these
differences may be why camel milk is highly digestible (Meena et al., 2014), it can
cause problem in technological applications (Khalesi et al., 2017). Camel milk is rich
in vitamins including B1, B2 and vitamin C (Ereifej et al., 2011). Particularly, vitamin
C in camel milk is almost three to five times higher than bovine milk, which makes
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camel milk an important part of diet, especially in arid areas where green foods have
limited accessibility (Zhao et al., 2015; Kamal & Karoui, 2017)
2.1 Protein Composition in Camel Milk
Protein content in the camel milk has been reported to vary with respect to
breed and season. For example, protein content was found to be highest in December
(2.9%) and lowest in August (2.48%) in the study reported by Haddadin et al. (2008).
Camel milk contains two major protein types; caseins and whey proteins. The camel
whey protein is not only composed of numerous soluble proteins, but also indigenous
proteases present in camel milk such as chymotrypsin A and cathepsin D (Alhaider et
al., 2013). Thus, the camel milk proteins themselves may be bioactive or could serve
as precursors for bioactive peptides.
2.1.1 Casein Proteins
Casein is the major protein in camel milk, which constitutes 52-87% of total
protein content (Khaskheli et al., 2005). Casein is composed of three main
components: αs1- casein, αs2-casein, and β-casein, and a fourth minor fraction casein. The major camel milk casein is β-casein (65% of total casein), which is higher
than the β-casein in bovine milk (36%). Similar to human milk, camel milk contains a
high percentage of β-casein that might reflect in its higher digestibility rate than bovine
milk: β-casein is more sensitive to pepsin hydrolysis than αS1-casein (El-Agamy et
al., 2009). On the other hand, camel milk has lower αs1-casein (21%), in comparison
to bovine αs1-CN (38%). The high percentage of β–casein in camel milk gives it a
higher digestibility rate and lower incidence of allergy in the gut of infants, as β-casein
is more easily hydrolyzed than αs-casein (El-Agamy et al., 2009). It has been reported
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that camel milk caseins have higher molecular masses in contrast to bovine caseins,
such that β-casein and α-casein were 28.6 kDa and 35 kDa respectively in camel milk,
while in bovine it was 24 kDa for β-casein, and 22-25 kDa for α-casein (Farah, 1986).
The -casein in camel milk is only 3.47% of total casein, whereas bovine milk
has 13% of –casein. Studies have shown that -casein is relatively harder to detect
because of its low concentrations in the camel milk (Farah & Atkins, 1992). The
hydrolysis sites for -casein in both camel and bovine milk differ; chymosin
hydrolyzes -casein at the Phe97-Ile98 bond in camel milk, while bovine –casein is
hydrolyzed at the Phe105-Met106 bond (Kappeler et al., 1998). Furthermore, it has been
observed that there is an additional proline residue in -casein, which plays a critical
role in the stability of camel milk (Kappeler et al., 1998).
Recently, the concentration of each casein component, except αS2-casein, was
determined in camel milk by capillary electrophoresis; it consisted of approximately
12.8 mg/mL of β-casein, 2.9 mg/mL of αS1-casein, and 1.7 mg/mL of -casein (Omar
et al., 2016).
2.1.2 Whey Proteins
In camel milk, whey constitutes about 30% of the total proteins (Zhao et al.,
2015)

and

are

mainly composed

of

α-lactalbumin

(α-LA),

lactophorin,

immunoglobulins (Ig), lactoferrin (Lf), and serum albumin (Ochirkhuyag et al., 1998;
Merin et al., 2001; El-Hatmi et al., 2006). Immunoglobulin G (IgG) is the dominant
immunoglobulin present in camel milk and the molecular weights of camel Ig differ
to those of bovine, sheep, goat and human (Alavi et al., 2018). α-LA and β –
lactoglobulin (β-LG) are the major difference between bovine and camel whey, such
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that camel whey lacks β–LG, which is the main component in bovine whey (50%) (ElAgamy et al., 2009). β–LG induces heat stability; hence the stability of camel milk is
poor at temperatures up to 140 ºC in contrast to bovine milk (Farah & Atkins, 1992;
Al-Saleh, 1996). α-LA is the major component of camel whey, while bovine whey has
only 25% of this protein (Farah, 1986; Farah & Atkins, 1992; Merin et al., 2001;
Laleye et al., 2008).
The molecular mass of α-LA in camel milk is reported to be 14.6 kDa with 123
residues, which is similar to bovine, goat and human milk (Beg et al., 1985, 1986).
However, the amino acid sequence of camel milk α-LA differs largely from that of
bovine, goat, and other species (Al Haj & Al Kanhal, 2010). Both camel and human
milk are known to contain high contents of α-LA and lactoferrin (Lf) (Hinz et al.,
2012). Lack of β-lactoglobulin, one of the major allergenic whey proteins in bovine
milk, makes camel milk a good substitute, with a potential to be used in infant formula.
The bioactive peptides which could be generated from camel whey proteins might
differ from bovine whey and other sources of whey proteins with respect to bioactive
properties.
Among the beneficial properties of camel milk, its anti-microbial activity is
mainly attributed to the high content of protective proteins in the whey fraction. Whey
proteins such as Lf, IgGs, lactoperoxidase, lysozyme, and other enzymes are potent
antimicrobial components in camel milk (El-Agamy et al., 1992; Konuspayeva et al.,
2005). All these anti-microbial constituents (except camel lactoperoxidase for which
no data are available) are present in significantly higher concentration in camel milk
compared to bovine milk and are known to be more thermostable (El-Agamy et al.,
2009). Therefore, camel whey proteins present a novel source of proteins which can
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generate bioactive peptides with potential health benefits.
2.2 Functional Properties of Camel Milk Proteins
Whey proteins have unique characteristics (Parodi, 2007). Apart from their
great importance in nutrition, they exhibit chemical, physical, physiological,
functional, and technological features useful in food application (McIntosh et al.,
1998). Based on these properties, more and more individual protein isolates and
protein concentrates of whey have been incorporated in food at industrial scale.
Therefore, whey proteins address two major issues in practice: nutritionally, they
supply energy and essential amino acids, and functionally, they help in modification
of texture, structure and overall appearance of food – e.g. gel formation, foam stability
and water retention.
Few studies have investigated the denaturation of camel whey proteins and its
effect on emulsifying, foaming, protein films and gel forming properties (Panyam &
Kilara, 1996). Technological properties such as thermal stability during drying, heat
induced aggregation, fouling properties and thin consistency have been explored in
fermented camel milk (Merin et al., 2001; El-Agamy, 2007; El-Hatmi et al., 2007;
Laleye et al., 2008). A recent study by Al Shamsi et al. (2018) produced camel milk
protein hydrolysates using proteolytic enzymes – alcalase, bromelain and papain. The
techno-functional properties like emulsifying activity index, surface hydrophobicity,
and protein solubility were investigated. It was found that these properties were higher
in the protein hydrolysates compared to unhydrolyzed camel milk proteins. Also, their
antioxidant potential was assessed in real food and in vitro systems. Thus, the potential
application of camel milk protein hydrolysates as a functional food ingredient due to
their enhanced techno-functional properties could be a novel approach.
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2.3 Milk Protein Hydrolysates, Bioactive Peptides and Their Production
Past research findings have proven proteins to be a good source of essential
amino acids. In addition, more recent research has been emerging which documents
other functionalities and bioactive properties of milk proteins demonstrated by
biologically active peptides. These peptides remain in an inactive state within the
parent protein molecule and demonstrate bioactive potential only when released from
the native protein (Khalesi et al., 2017).
Bioactive peptides are defined as those peptides that consist of specific protein
fragments which show biological activity and may be beneficial in promoting health
(Kitts & Weiler, 2003). The hydrolysis (or breakdown) of proteins to get these peptides
can be from various sources, but at present, milk derived peptides are the most
important source (Korhonen, 2009). Many studies have reviewed the production and
properties of peptides from milk proteins (Clare & Swaisgood, 2000; Korhonen &
Pihlanto, 2003; Pihlanto & Korhonen, 2003; Meisel, 2005; Silva & Malcata, 2005;
Korhonen & Pihlanto, 2006). Several bioactive peptides seem to have beneficial health
effects on digestive, cardiovascular, immune and nervous systems (HernándezLedesma et al., 2011; Korhonen & Pihlanto, 2006). The active sequences may be from
2 to 20 amino acids long (Korhonen, 2009).
Biologically active peptides can be produced from milk proteins in three
different ways: 1) enzymatic hydrolysis (using digestive or microorganisms and plant
derived enzymes), 2) fermentation (using proteolytic starter cultures), and 3) heating
under alkali/acid conditions (Pihlanto-Leppälä, 2000; Muro Urista et al., 2011).
Sometimes, a combination of the above methods also helps in obtaining highly potent
peptide fractions with diverse bioactive properties (Korhonen, 2009).
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2.3.1 In Vitro Enzymatic Hydrolysis
Controlled enzymatic hydrolysis is critical in producing hydrolysates for three
reasons: (i) to preserve the properties of generated products, peptides and amino acids
(Tavano, 2013), (ii) to avoid excessive protein hydrolysis that can (a) result in bitter
flavored peptides (Jung et al., 2005) and (b) hinder functionality, and (iii) to maintain
the improved solubility in the protein as a result of the hydrolysis process (Tavano,
2013). Thus, by controlling the degree of hydrolysis, one may be able to obtain and
explain the potential bioactive and/or functional properties of the protein hydrolysates.
In this process, whole protein molecule undergoes hydrolysis (or breakdown)
by enzymes like pepsin, trypsin, and chymotrypsin. These enzymes can mimic
gastrointestinal digestion effects on the food peptides (Tavano, 2013). Other
proteolytic enzymes such as alcalase, subtilisin, and thermolysin are used in
conjunction with pepsin and trypsin to generate peptides with known biological
activities (Agyei & Danquah, 2011). Liberation of peptides with a wide range of
actions can thus be achieved using different enzymes (Tavano, 2013). The bioactivity
of peptides has been extensively reported in literature, although the mechanism of
actions is not well understood. Few studies hypothesize it as a structure-activity
relationship, while others suggest that the enzyme can be chosen to get the desired
fragment and effect (Tavano, 2013).
The milk protein hydrolysates can be produced from different casein or whey
proteins (Meisel & FitzGerald, 2003; Yamamoto et al., 2003; FitzGerald et al., 2004;
Gobbetti et al., 2004). Casein hydrolysates have been reported to produce good ACEinhibitory peptides (Otte et al., 2007), while whey peptides with sequence Ile-Leu-Pro-
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Met-His-Ile-Arg from 𝛽-LG have also been identified to have strong antihypertensive
activity (Mullally et al., 1997; Maes et al., 2004).
2.4 Bioactive Properties of Whey Protein Hydrolysates
Whey is a good source of nutrients and important peptides. To concentrate
whey proteins and obtain nutritional value, several technologies like heating, drying,
reverse osmosis, and membrane separation have been applied. Another approach is
hydrolysis of whey to produce hydrolysates containing bioactive peptides. These
peptides can be released by enzymatic hydrolysis in vitro as discussed previously.
Thereafter, bioactive peptides from whey protein can act on major organ systems of
the body and impart physiological functions to these systems (Sharma, 2014). Milk
protein hydrolysates are known to possess various bioactive properties as discussed
below.
2.4.1 Antioxidant Activity
Oxidation of food is a major concern in food spoilage. Lipid oxidation not
only deteriorates the food quality, but also shortens the shelf life and generates free
radicals that can in turn cause decomposition of fatty acids, which may decrease the
safety and nutritional value of the food. Thus, it is critical to hinder lipid oxidation
process and formation of free radicals (Peng et al., 2009). Synthetic antioxidants have
been incorporated into food products and prove to be cost-effective and efficient, but
their potential toxic effects to human health have led manufacturers to seek natural
antioxidants (Ito et al., 1985).
Enzymatic hydrolysis of milk proteins, particularly those from bovine has been
widely explored for generation of bioactive peptides with potential antioxidant
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properties. For example, antioxidant peptides from bovine αs-casein showed
properties like free-radical scavenging and inhibition of enzymatic and non-enzymatic
lipid peroxidation (Rival et al., 2001). Hydrolysis of bovine whey proteins have also
resulted in peptides that may have antioxidant activity (Zhang et al., 2013).
The principle mechanism behind antioxidant activity of peptides is not very
well understood, but studies have shown that they are free radical scavengers
(Rajapakse et al., 2005; Moure et al., 2006; Qian et al., 2008), metal ions chelators
(Rajapakse et al., 2005) and inhibitors of lipid peroxidation (Wu et al., 2003; Moure
et al., 2006; Qian et al., 2008). Antioxidant properties of the peptides are influenced
by their structure, composition, hydrophobicity, and peptide sequence (Chen et al.,
1998; Rajapakse et al., 2005). Other factors affecting antioxidant activity of bioactive
peptides include degree of hydrolysis, type of protease (Peñta-Ramos et al., 2002;
Gibbs et al., 2004), peptide structure (Saito et al., 2003), and peptide concentration
(Chen et al., 2007). Some recent studies have started exploring camel milk as a
potential protein substrate for generating bioactive protein hydrolysates with
antioxidant activities (Al-Saleh et al., 2014; Shori, 2014) which are summarized in
Table 1. Other studies like those of Jrad et al. (2014a) and Salami et al. (2011) have
reported higher antioxidant activity of camel milk casein hydrolysates when digested
with gastrointestinal enzymes.
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Table 1: Antioxidant activity of bioactive protein hydrolysates obtained from camel
milk or colostrum proteins
Protein source

In vitro test

Results

Reference

𝛼-LA from camel
whey

ABTS

Greater antioxidant activity
compared to bovine 𝛼-LA

Salami et al. (2009)

Camel colostrum,
colostral whey
protein

ABTS

Radical scavenging activity
increased following
enzymatic digestion

Jrad et al. (2014b)

Whey protein + its
hydrolysates

ABTS

Higher antioxidant activity
compared to bovine whey
protein and their
hydrolysates

Salami et al. (2010)

Fermented camel
milk peptide
fractions (casein)

ABTS

More pronounced
scavenging activity than
bovine milk

Moslehishad et al.
(2013)

Camel milk casein

ABTS,
FRAP, DPPH

Antioxidant activity
increased significantly

Kumar et al.
(2016a)

Whole camel milk
protein hydrolysates

ABTS,
FRAP,
DPPH, Iron
chelating
activity

ABTS, DPPH, and Iron
chelating activities
increased, however, FRAP
did not showed a
significant enhancement
upon hydrolysis.

Al Shamsi et al.
(2018)

Based on the chemical reactions, the assays determining the antioxidant
capacity can be categorized into two groups: 1) methods based on electron transfer
(ET) like the ferric ion reducing antioxidant power (FRAP) and 2,2-diphenyl-1picrylhydrazyl (DPPH) radical-scavenging assay (MacDonald-Wicks et al., 2006, and
2) methods based on hydrogen atom transfer (HAT) like oxygen radical absorbance
capacity (ORAC) and total radical trapping antioxidant parameter (TRAP) assay
(Huang et al., 2005; Sarmadi & Ismail, 2010).
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2.4.2 Antimicrobial Activity
Contamination of food products by pathogenic and spoilage bacteria is of
significant concern in the food industry. To preserve the shelf life and safety of food
product as well as to prevent further growth of such bacteria, several methods have
been employed, which include use of synthetic and natural antimicrobial agents. Due
to synthetic agents causing a detrimental impact on the human health and the
environment, manufacturers are incorporating more natural sources of antimicrobial
agents in the food, but there is a need for novel antimicrobial agents (Brandelli et al.,
2015). Past literature shows a few strategies to improve the antimicrobial activities of
proteins such as enzymatic hydrolysis (Korhonen & Pihlanto, 2006; Théolier et al.,
2013) and esterification (Sitohy et al., 2013). Another way to produce anti-microbial
peptides is by the hydrolysis of casein proteins during fermentation with proteolytic
bacterial strains (Hayes et al., 2006). Furthermore, anti-microbial peptides have also
been extracted from different cheese varieties (Rizzello et al., 2005; Lignitto et al.,
2012).
Whey

proteins

like

lactoferrin,

lysozyme,

lactoperoxidase

and

immunoglobulins are the most studied till date (Chatterton et al., 2006). More recently,
antibacterial fragments have also been derived from other whey proteins such as α-LA
and β-LG (Atanasova & Ivanova, 2010). Assessment of antimicrobial potential of
whey protein hydrolysates and peptides is carried out in vitro. Once the peptide
sequence is identified and synthesized, the sequences are tested against strains of
bacteria to affirm the antimicrobial activity (Brandelli et al., 2015). The antimicrobial
efficacy of the bioactive peptides is influenced by several factors like the load,
structural diversity (Gennaro & Zanetti, 2000), hydrophobicity (Kustanovich et al.,
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2002), and specific amino acid composition, such as histidine, arginine, proline,
cysteines and glycine (Andreu & Rivas, 1998).
Recently, goat whey hydrolysates were produced using alcalase from Bacillus
licheniformis (Osman et al., 2016) and fractionated by size exclusion chromatography
(SEC). The hydrolysates showed enhanced antibacterial activity when compared to
unhydrolyzed goat whey. Another study on goat whey proteins used pepsin enzyme
which produced peptides with considerable antibacterial activity (El-Zahar et al.,
2004). Théolier et al. (2013) assessed the whey protein isolate hydrolyzed by
gastrointestinal enzymes. Trypsin and chymotrypsin hydrolysates did not show
antimicrobial activity, while pepsin derived peptides exhibited considerable activity
despite their weak degree of hydrolysis. Furthermore, goat whey proteins digested by
human gastric and duodenal juice have also been investigated and their inhibition
against pathogenic bacteria has been reported (Almaas et al., 2008).
Limited studies have been conducted on camel milk proteins and their
hydrolysates for their antimicrobial activities. Camel caseins were enzymatically
digested, and the antibacterial activities of the digested sample were evaluated against
Gram-positive (Listeria monocytogenes, Bacillus cereus, and Staphylococcus aureus)
and Gram-negative (Escherichia coli) bacteria (Kumar et al., 2016b). It was found that
casein hydrolysate produced by alcalase showed highest inhibitory activity (17.93 ±
0.82) against E. coli. Salami et al. (2010) reported that enzymatic hydrolysis of camel
and bovine whey proteins improved the antimicrobial effects against E. coli, however,
the degree of hydrolysis with chymotrypsin and trypsin was low, thus the antimicrobial
activity was not enhanced. There is a need to explore antimicrobial properties of camel
milk whey protein hydrolysates in-depth using different proteolytic enzymes and
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experimental conditions and test them against a wide range of pathogenic microbes in
vitro as well as in vivo.
2.4.3 ACE Inhibitory Activity
Among the bioactive properties demonstrated by the milk bioactive peptides,
ACE inhibitory activities are widely reported (Phelan & Kerins, 2011). A dipeptidyl
carboxypeptidase, ACE catalyzes the conversion of inactive angiotensin I peptide into
angiotensin II peptide which is a potent vasoconstrictor. Angiotensin II is responsible
for increasing the salt levels which raises the blood pressure. ACE inhibitor drugs are
commonly prescribed in individuals suffering from hypertension or related
cardiovascular disorders (Acharya et al., 2003). Several peptides that inhibit ACE have
been reviewed and reported after enzymatic hydrolysis of milk proteins and after
fermentation of milk with Lactobacillus (Hernández-Ledesma et al., 2014). Among
the most studied ACE-inhibitory peptides are valine-proline-proline [VPP; β-casein
f(84e86)] and isoleucine-proline-proline [IPP; β-casein f (74e76)] which have been
derived from bovine caseins following fermentation with Lactobacillus (Solieri et al.,
2015). Moreover, a bovine whey protein concentrate hydrolyzed with alcalase showed
potent antihypertensive effect (da Costa et al., 2007).
Studies on the ACE-inhibitory activities of camel milk protein-derived
peptides are very few and have been summarized in Table 2. Alhaj et al. (2018)
fermented camel milk using two types of strains (Lactobacillus helveticus or
Lactobacillus acidophilus with Streptococcus thermophilus) and determined the ACE
activity of fermented and unfermented camel milk. Pihlanto et al. (2010) also
investigated fermented camel milk’s inhibitory activity towards ACE. They used LAB
strains and found seven fermented camel milk samples that showed highest ACE
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inhibitory activity, along with a correlation between degree of hydrolysis and ACE
inhibition. ACE-inhibitory peptides can be identified using reversed-phase HPLC (RPHPLC) (Mota et al., 2004) or be quantified using triple mass spectrometry (HPLCMS3) (Bütikofer et al., 2007).
Table 2: Antihypertensive activity of camel milk and its protein hydrolysates
generated by fermentation with probiotic bacteria or exogenous enzymes
Source

Results

Camel milk fermented with

Peptides purified from

Lactobacillus helveticus 130B4

fermented camel milk

Reference
Quan et al. (2008)

inhibited ACE
Camel whole casein + camel 𝛽-

Increased ACE-inhibitory

casein (using pepsin, trypsin,

activity

Salami et al. (2011)

chymotrypsin and a mixture of
all three enzymes)
Peptide fractions from fermented

Significantly high ACE-

Moslehishad et al.

camel and bovine milk by

inhibitory activity of

(2013)

Lactobacillus rhamnosus PTCC

cultured camel milk than

1637

bovine milk

Skimmed camel milk digested

ACE-inhibitory peptides

Tagliazucchi et al.

using pepsin, 𝛼-amylase, and

released; highest activity for

(2016)

pancreatin

post-pancreatic fraction.
Also, anti-hypertensive
tripeptide IPP quantified in
digested camel milk.
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2.4.4 Antidiabetic Activity
Diabetes mellitus affects millions of people around the globe. It is a chronic
condition in which the body is either unable to produce enough insulin, can’t use the
produced insulin or a combination of both. Clinical studies and murine models have
demonstrated that consumption of camel milk by type 1 diabetes patients lowered the
blood glucose level (Agrawal et al., 2005b, 2007a; Sahani et al., 2005). Although the
mechanism isn’t fully understood, camel milk appears to have an insulin-like protein
that resists intestinal digestions, absorbs faster into blood, possesses larger lipid
micelles and has different casein content (Beg et al., 1986; Ramet, 2001; Agrawal et
al., 2004a). Agrawal et al. (2007a, 2007b) showed that the lack of camel milk
coagulation in the human stomach and the influence of small size immunoglobulins of
camel milk on β-cells have also added to the possible hypoglycemic effect. A recent
in vitro study reported a potentiating effect of camel milk proteins on insulin receptor
activity expressed in HEK293 cells, which may be a possible mechanism of action
(Abdulrahman et al., 2016). Jakubowicz and Froy (2013) suggested that whey proteins
and their hydrolysates seem to stimulate secretion of gut hormones in vivo by releasing
bioactive peptides and amino acids, thereby helping mediate glycaemia. Furthermore,
these peptides can act as dipeptidyl peptidase-4 (DPP-IV) inhibitors in vivo. Since
DPP-IV inhibition has helped in managing type-2 diabetes, several DPP-IV inhibitory
peptides have been isolated and identified from bovine casein (Lacroix & Li-Chan,
2012a, 2013, 2014; Uenishi et al., 2012; Nongonierma & FitzGerald, 2013a, 2013b;
Silveira et al., 2013) and caprine casein (Zhang et al., 2016). Brandelli et al. (2015)
summarized in their review paper that DPP-IV inhibitory peptides from hydrolysates
are more likely to have molecular masses below 2 kDa and most of them contain
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hydrophobic amino acid residues (Lacroix & Li-Chan, 2012a).
Much work has been done on diabetic rats treated with raw or fresh camel milk
where there was significant reduction in plasma glucose levels (Agrawal et al., 2005a,
2005b; Kamal et al., 2007, Al-Numair et al., 2011, Hamad et al., 2011; Khan et al.,
2013). Camel milk whey protein displayed a significant reduction in blood glucose
levels from 411 ± 37 mg/dL to 261 ± 25.5 mg/dL in Streptozotocin (STZ)-induced
diabetic mice (Badr, 2013). The study also reported that diabetic mice treated with
camel milk whey protein showed higher levels of insulin in comparison to untreated
diabetic mice. In a recent research article, Mahmoud et al. (2016) demonstrated camel
whey protein’s protective effects in STZ-induced diabetic pregnant mice’s off-springs.
It was found that when camel whey protein was administered orally as a supplement
to diabetic pregnant mice, several postpartum complications like increased levels of
reactive oxygen species, pro-inflammatory cytokines, overexpression of activating
transcription factors, and other immune-related functions significantly reduced in the
offspring. Intact proteins from camel milk and camel whey have been reported to
possess anti-diabetic property, however, there is no study conducted on bioactive
peptides produced from camel whey proteins possessing anti-diabetic properties. A
recent study identified novel DPP-IV inhibitory peptides (Leu-Pro-Val-Pro-Gln and
Trp-Lys) from camel milk protein hydrolysates, which were not found in bovine milk
protein hydrolysate. An in-silico approach was undertaken where camel milk protein
was hydrolyzed with trypsin to obtain potent DPP-IV inhibitory peptides
(Nongonierma et al., 2017c). Another study identified nine novel DPP-IV inhibitory
peptides from trypsin digested camel milk proteins, of which two LPVP and MPVQA
had IC50 values <100 uM (Nongonierma et al., 2018). These studies on camel milk
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protein hydrolysates provide strong indication that the camel whey protein fraction
upon hydrolysis might demonstrate effective antidiabetic activities.
2.4.5 Anticholesterol Activity
Studies on dietary proteins derived from soybean (Anderson et al., 1995;
Carroll & Kurowska, 1995; Potter, 1995; Hori et al., 2001), and fish (Zhang & Beynen,
1993; Wergedahl et al., 2004) have been proposed to improve blood lipid profile in
humans and animal experiments. Milk derived bioactive peptides from whey have
been reported to display similar effects, albeit to a lesser extent. For instance, Nagaoka
et al. (2001) identified a novel hypocholesterolemic peptide from tryptic digestion of
𝛽-LG and tested it in Caco-2 cells and animal studies. Liver and serum cholesterol
levels were markedly lower in rats administered with the tryptic hydrolysate. Inhibition
of micellar solubility of cholesterol was attributed to be the reason for decrease in
cholesterol absorption. In another study it was found that the water-soluble lactostatin
was able to increase cholesterol mechanism by activating the transcription of
cholesterol 7a-hydroxylase (CYP7A1) gene (Morikawa et al., 2007).
Previous studies report that bovine casein tends to elevate blood cholesterol
level due to its high methionine-glycine and lysine-arginine ratios, but the mechanism
is not understood (Jacobucci et al., 2011). Comparing casein with other proteins like
soy, fish and whey, it was suggested that these proteins could alter the plasma profile
by decreasing atherogenesis and having a cardio-protective effect (Erdmann et al.,
2008).
A study on the effects of fermented camel milk (gariss G) and Gariss
containing Bifidobacterium (G+Bb+12) on plasma and liver cholesterol levels in rats
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was performed (Elayan et al., 2010). Decrease in plasma low-density lipoprotein and
plasma triglycerides was observed. Also, liver cholesterol levels were much lower in
rats fed on (G) and (G+Bb+12) diets as compared to rats on positive control
(cholesterol-enrich) diets.
Few studies on fermented bovine and camel milk’s cholesterol lowering
activity have been reported. Damodharan et al. (2016) isolated Lactobacillus
helveticus strains KII13 and KHI1 from fermented bovine milk. KII13 displayed a
higher cholesterol-lowering activity (47%) than KHI1 (28%) in vitro. The strain was
then selected for their in vivo study in atherogenic diet-fed hypercholesterolemic mice.
Serum total cholesterol and LDL levels showed a decrease in mice fed with fermented
bovine milk. Also, cholesterol metabolism-related gene expression of LDLR and
SREBF2 was enhanced in mice fed with KII13. Another study also investigated
selected LAB strains from raw camel milk (Abushelaibi et al., 2017). Among the
isolates identified, Lactococcus lactis KX881768, Lactobacillus plantarum
KX881772, Lactococcus lactis KX881782 and Lactobacillus plantarum KX881779
were reported to be highly effective in their cholesterol removing abilities.
2.5 Characterization of Milk Protein Hydrolysates
Characterization of milk derived protein hydrolysates based on size of the
peptides, amino acid sequence, chemical modification during processing, storage etc.
is important. For this, separation, identification, and quantitative determination of
peptides is needed since peptides are part of complex mixtures (Sharma, 2014).
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2.5.1 Conventional Methods for Characterizing Protein Hydrolysates
2.5.1.1 Electrophoretic Methods
Polyacrylamide gel electrophoresis (PAGE) is widely used in laboratories
where researchers are studying milk proteins and milk-derived protein hydrolysates.
The separation here occurs according to the peptides’ mass to charge ratio, isoelectric
pH, or molecular weight. Thus, there are different types of PAGE which can be used
according to the separation respectively: native or urea PAGE, isoelectric focusing
(IEF) or sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Capillary electrophoresis (CE) is another method that allows for a much higher
accuracy and precision in the quantitative determination of peptides, in contrast to
conventional PAGE method (Strickland et al., 2001). CE can separate small to large
sized peptides, making it an attractive option. In a recent study, Omar et al. (2016)
separated and quantified proteins from camel milk using CE. Three peaks related to 𝛼LA, Lf, and serum albumin were identified, while no peak of 𝛽-LG was detected. They
used bovine milk standards to compare and found 𝛽-LG to be the main whey protein
in bovine milk followed by 𝛼-LA and bovine serum albumin. Quantification of major
whey proteins in camel milk showed 𝛼-LA as the main one with a higher concentration
(2.01 ± 0.02 mg/mL) than that of 𝛼-LA in bovine milk (1.08 ± 0.04 mg/mL). Similarly,
the major camel casein proteins were quantified, and the results were in accordance
with the data reported in earlier studies (Al haj & Al Kanhal, 2010; Ereifej et al., 2011)
2.5.1.2 Chromatographic Methods
Different chromatographic techniques have been used to characterize protein
hydrolysates. These include size exclusion-fast protein liquid chromatography and size
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exclusion-high performance liquid chromatography (HPLC). These techniques can
determine molecular masses of large to medium sized peptides, while for small sized
peptides, reversed phase liquid chromatography (RP-HPLC) can be employed
(Flanagan & FitzGerald, 2002). In RP-HPLC, retention time depends on the amino
acid composition of small peptides while for larger peptides, retention time is
influenced by molecular weight and conformational effects. Because RP-HPLC
profiles of milk protein hydrolysates cover thousands of peptides of different chemical
and genetic variants, statistical tools help researchers obtain only relevant information
from such large data (Coker et al., 2005). In the characterization of hydrolysates
containing large number of peptides, RP-HPLC requires considerable number of
separation steps to detect a specific peptide without any interference (Tzvetkova et al.,
2007; Noilet & Toldra, 2009). An example of a study where RP-HPLC was used to
separate and quantify genetic variants of casein and whey protein was done on water
buffalo milk. They reported separation of all major protein fractions with improved
resolution, and in a shorter time (Bonfatti et al., 2013).
2.5.1.3 Mass Spectrometry
This technique is considered an important tool for analyzing proteins and
peptides and has advantages like high speed, high sensitivity and small sample size
over conventional methods. A combination of inlets, ion sources, and mass analyzers
are utilized for analysis of milk peptides giving configurations like HPLCelectrospray-quadrupole mass spectrometer, HPLC-electrospray-ion-trap mass
spectrometry or direct probe matric-assisted laser desorption/ionization-time-of-flight
mass spectrometer (MALDI-TOF) (Nollet & Toldrá, 2016).
Quadrupole mass spectrometers can transmit only the ions of a certain

25
mass/charge ratio (m/z) which reach the detector making it less sensitive. In contrast,
ions of any m/z can be transmitted and detected in the time of flight (TOF) system
making it highly sensitive and efficient (Nollet & Toldrá, 2016).
2.5.2 New Method: Proteomic Analysis of Milk Proteins and Peptides
Peptide analysis by mass spectrometry involves a proteomic approach to
characterize milk proteins. The approach can be either gel-based or gel free technique.
In gel-based approach, protein fraction retained at specific molecular weight is
separated, the protein digestion takes place using enzymes, and finally sequencing of
the obtained peptides is done by mass spectrometry or in combination with another
separation technique (HPLC/CE). This approach has limitations like analyzing
proteins of very low or very high molecular masses, and extreme isoelectric point or
hydrophobicities (Nollet & Toldrá, 2016). A second proteomic approach involves
digestion of all proteins in solution, followed by fractionation of peptides by 2D
chromatography, and then identification of the peptides by mass spectrometry
(O’donnell et al., 2004; Guy & Fenaille, 2006).
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Chapter 3: Methods
3.1 Enzymes and Reagents
Pepsin from porcine gastric mucosa (EC 3.4.23.1, 250 units/mg protein), 𝛼chymotrypsin from bovine pancreas (EC 3.4.21.1, ≥40 units/mg protein), trypsin from
bovine pancreas (EC 3.4.21.4, ≥8.500 units/mg), angiotensin-I converting enzyme
(ACE) from rabbit lung (E.C 3.4.15.1, ≥2.0 units/mg protein), α-Glucosidase from
Saccharomyces cerevisiae (type I, lyophilized powder, >10 units/mg protein, EC
3.2.1.20), α-amylase from porcine pancreas (EC 3.2.1.1), DPP-IV from human (EC
3.4.14.5), porcine pancreatic lipase (EC 3.1.1.3), cholesterol esterase enzyme (porcine
pancreas, EC 3.1.1.13, ~35 U/mg) were purchased from Sigma-Aldrich Chemical
Company (St. Louis, MO, U.S.A).
Chemical reagents including acetonitrile, methanol of HPLC grade,
trifluoroacetic acid (TFA), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
(Trolox), o-phthaldialdehyde (OPA), 2,2-azinobis (3-ethylbenzthiazoline-6-sulfonic
acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH) and purified bovine milk
standards (over 90% purity) were obtained from Sigma-Aldrich (USA). Other
chemicals were purchased from BDH middle east and were of analytical grade. All
solutions were prepared using deionized water and kept at 4°C until further use.
3.2 Camel Milk Sample Collection
Raw camel milk was procured from local camel farms in Al Ain, United Arab
Emirates (UAE). Milk was collected from 3-4 healthy female camels (Camelus
dromedarius, local breed) and pooled together to be used as a composite sample. Milk
was then transported to the Laboratory at Food Science Department, UAEU in chilled

27
condition. After arrival in the laboratory, the samples were stored at 4°C and processed
no later than 2 hrs.
3.3 Camel Whey Protein Separation
Camel milk was skimmed via centrifugation at 4700 x g for 10 min, at 15°C
using a refrigerated centrifuge (Beckman Coulter, Allegra X-30R). The pH of
skimmed milk was adjusted to 4.6 with 6 N HCl using a digital pH meter (Starter 3100,
Ohaus, USA) and allowed to settle for 1 h. This was followed by centrifugation at 4700
x g at 4°C for 10 min which resulted in casein pellets and whey supernatant. Collected
whey supernatant was once again centrifuged to remove any remaining casein
fractions. One portion of the whey protein fraction was kept as control, whereas the
remaining portion was distributed in three batches for enzymatic hydrolysis by each
enzyme.
3.4 Production of Camel Whey Protein Hydrolysates
Hydrolysis of camel whey proteins was carried out by using three proteolytic
enzymes - pepsin, trypsin and chymotrypsin. Enzymatic hydrolysis was carried out at
the optimal conditions of pH and temperature for each enzyme (Table 3) (Osman et
al., 2016).
Table 3: Hydrolysis conditions for production of camel whey protein hydrolysates
Enzyme

Enzyme/substrate ratio

pH

Time (h)

Temperature
(°C)

Pepsin

1/100

4.0

3, 6

37

Chymotrypsin

1/100

8.0

3, 6

55

Trypsin

1/100

8.0

3, 6

55
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Whey proteins were divided into six groups with three replicates each for each type of
hydrolysate. The protein content in each hydrolysate was determined by Biuret test
and found to be 3.07%. The enzymatic solution was prepared by solubilizing known
concentration of the enzymes in 25 ml of whey samples in order to obtain an enzyme:
substrate ratio of 1:100. The pH of whey samples was adjusted to the optimum value
for each enzyme (pH 2 for pepsin and 8 for trypsin and chymotrypsin) and monitored
by a digital pH meter (Starter 3100, Ohaus, Parsippany, NJ). Then, the whey samples
were heated to an optimal temperature for each enzyme (37°C for pepsin and 55°C for
trypsin and chymotrypsin) in a Vaseline bath under constant agitation (752A model,
Fisatom, São Paulo, SP, Brazil). The samples were incubated for 3 h and 6 h of
hydrolysis time for each enzyme and thereafter the enzymes were heat deactivated at
95°C for 10 mins. The samples were centrifuged (10,000 x g, 15 min, 4°C) and
supernatant was collected and stored at -20°C for further analysis.
3.5 Characterization of Camel Whey Protein Hydrolysates
3.5.1 Degree of Hydrolysis
Degree of hydrolysis (DH) was analyzed using the o-phthalaldehyde (OPA)
method described by Nielsen et al. (2001) and Donkor et al. (2007) with a few
modifications. The OPA reagent was prepared freshly by combining 25 ml of sodium
tetraborate buffer (100 mM; pH 9.3), 2.5 mL of sodium dodecyl sulfate SDS (20%,
wt/wt), 40 mg of OPA (dissolved in 1 mL of methanol), and 100 µL of βmercaptoethanol and diluted to 50 mL with water. The serine standard (0.9516 meqv/l)
was prepared by dissolving 50 mg serine (Sigma Aldrich, USA) in 500 mL deionized
water. Three milliliters of 0.75 M trichloroacetic acid (TCA) was added to 3 mL
aliquots of whey samples; and incubated for 10 min at room temperature. The mixture
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was centrifuged at 4000 x g for 30 min at 4°C The supernatant was passed through a
0.45 µm syringe filter and stored at 20°C until assayed. Small aliquots (100µL) of the
samples were added to a test tube containing 1 ml of the OPA reagent and mixed gently
for 5 seconds. The absorbance (Asample) was measured at 340 nm using a NovaSpec-II
Spectrophotometer (Pharmacia, England, UK) after exactly two minutes of incubation
at room temperature. The experimental steps were repeated with milli-Q water as a
blank (Elix-10, Millipore, Molsheim, France) and with the serine solution as standard
(Astandard). Degree of hydrolysis was determined by using DH (%) =h/ htot x 100 where,
htot was the total number of peptide bonds per protein equivalent and h was the number
of hydrolysed bonds, which was determined by using h = (Serine NH2 – β)/α.
3.5.2 Reversed-Phase High-Performance Liquid Chromatography
The method described by Bobe et al. (1998) with slight modifications was used
to characterize the non-hydrolyzed and hydrolyzed camel whey proteins on RP-HPLC
system (Thermoscientific, Germering, Germany). Protein analysis was performed on
a Reversed Phase Column C-18 (250 mm length x 4.6 mm internal diameter)
(Thermoscientific, Germering, Germany). Camel whey and whey hydrolysate samples
(30 mg/mL) were dissolved in solvent (acetonitrile, water, and trifluoroacetic acid in
a ratio 100:900:1 (v/v/v)) and using a 0.45 µm cellulose acetate filter, insoluble
particles were removed by filtration. The filtrate was injected (5 µL) on the column.
Chromatographic separation was performed in reverse phase mode using a C-18
column maintained at 25°C with a flow rate of 1 mL/min, using a linear acetonitrile
gradient, starting with 2.5 min 100% buffer A (water, 0.13% TFA), followed by a
linear gradient to 40% buffer B (100% acetonitrile, 0.13% TFA) for 10 min. The
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detection wavelength was 220 nm. Analysis of whey protein hydrolysate produced by
different enzymes for 3 and 6 h was carried out.
3.6 Different Bioactivities of Camel Whey Protein Hydrolysates
3.6.1 Antioxidant Activity
3.6.1.1 DPPH Radical Scavenging Activity
DPPH radical-scavenging activity was determined by the method described by
Wu et al. (2003). To the sample (1.5 mL), 1.5 mL of 0.15 mM 2,2-diphenyl-1-picryl
hydrazyl (DPPH) in 95% ethanol was added and vigorously mixed. The mixture was
then allowed to stand at room temperature in the dark for 30 min. The absorbance was
measured at 517 nm using a UV-1800 spectrophotometer (Shimadzu, Kyoto, Japan).
Preparation of the blank was same, except that the sample was replaced with distilled
water. A standard curve of Trolox in the range of 10–60 μM was prepared and the
activity was expressed as μmol Trolox equivalents (TE)/g protein of hydrolysate.
3.6.1.2 ABTS Radical Scavenging Activity
ABTS radical scavenging activity was assayed as per the method of Arnao et
al. (2001) with a slight modification. The stock solutions included 7.4 mM ABTS
solution and 2.6 mM potassium persulphate solution. The working solution was
prepared by mixing the two stock solutions in equal quantities and allowing them to
react for 12 h at room temperature in the dark. The solution was then diluted by mixing
1 mL ABTS solution with 50 mL methanol to obtain an absorbance of 1.1 ± 0.02 units
at 734 nm using a UV-1601 spectrophotometer (Shimadzu, Kyoto, Japan). A fresh
ABTS solution was prepared for each assay. Samples (150 μL) with a concentration
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range of 0.5–10 mg/l were mixed with 2850 μL of ABTS solution and the mixture was
left at room temperature for 2 h in dark. The absorbance was then measured at 734 nm
using the spectrophotometer. A sample blank at each concentration was prepared in
the same manner except that methanol was used instead of ABTS solution. A standard
curve of Trolox ranging from 50 to 600 μM was prepared. The activity was expressed
as μmol Trolox equivalents (TE)/mL of phenolic compounds.
3.6.1.3 FRAP Assay
The reducing ability of hydrolyzed whey was measured using the ferric
reducing/antioxidant power (FRAP) assay by the method of Benzie and Strain (1996)
as modified by Maqsood and Benjakul (2010). Working FRAP reagent was prepared
by mixing 2.5 mL of 10 mM TPTZ (2,4,6-tripyridyl-s-triazine) solution in 40 mM HCl
plus 2.5 mL of 20 mM FeCl3. 6H2O and 25 mL of 0.3 mM acetate buffer (pH 3.6).
Aliquots of 3.0 mL each of freshly prepared FRAP reagent were mixed with 0.3 mL
of distilled water and 0.1 mL of hydrolyzed whey protein samples (45 mg/mL).
Absorbance (593 nm) of sample as well as blank solutions was taken at 30 s intervals
for up to 8 min. Sample FRAP values were calculated based on Trolox standard curve
prepared with 10-60 μM and were expressed as Trolox equivalent (μM).
3.6.1.4 Ferrous Ion Chelating Activity
The chelation of Fe2+ was measured using the method of Boyer and McCleary
(1987), with slight modification. Diluted whey hydrolysate samples (4.7 mL) were
mixed with 0.1 mL of 2 mM FeCl2 and 0.2 mL of 5 mM ferrozine. The reaction
mixture was made to stand for 20 min at room temperature. The absorbance was then
read at 562 nm. The blank was prepared by using the distilled water instead of the
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sample. The chelating activity was calculated as follows: Chelating activity (%)=[(BA)/B] ×100, where A is absorbance of the sample and B is absorbance of the blank.
3.6.2 Antimicrobial Activity
The antimicrobial activity of camel whey protein hydrolysates (CWPHs) was
evaluated as per the method of Shavandi et al. (2017) and Esmaeilpour et al. (2017)
with some modifications. Five common human pathogenic bacterial strains including
two Gram positive (Staphylococcus aureus ATCC 15923 and Listeria monocytogenes
ATCC 7644 (Sigma-Aldrich, USA) and three Gram negative bacteria (Salmonella
typhimurium ATCC 14028, Cronobacter sakazakii ATCC 29544 and Escherichia coli
ATCC 35218 ESBL (Sigma-Aldrich, USA) were used as indicator organisms.
Indicator micro-organisms were incubated overnight in Mueller Hinton broth (MHB)
medium at 37°C and working cultures were obtained by diluting to approximately 6.0
log CFU/mL using sterile MHB medium. The antimicrobial activity was assessed by
observing growth of indicator micro-organisms in presence or absence of test samples
in a sterile 96-well microplate after 24 h of incubation at 37°C. For this, 100 μL of
indicator micro-organism was mixed with 50 μL of test sample and 50 μL of fresh
MHB medium. For control, test sample was replaced with 50 μL of sterile water. The
optical density of wells was measured at 0 h and 24 h (37°C) at 595 nm using a
microplate reader (AMP Platos R 496, Austria). Percent inhibition after 24 h of
incubation was calculated according to Casey et al. (2004):
% growth inhibition = (control -test)/ control x 100.
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3.6.3 Antihypertensive Activity
ACE inhibition activity of the whey protein hydrolysates was determined by
an HPLC method modified from Rufián-Henares and Morales (2007). ACE-inhibitory
activity is quantified by hippuric acid formation in vitro by causing hippuryl-histidylleucine (HHL) to interact with the ACE from rabbit lung, both in the presence and
absence of inhibitor. 50 μL of ACE solution (20 mU) was added to 150 mM borate
buffer (pH 8.3, 300 mM NaCl), along with 50 μL of sample solution, and 50 μL of 20
mM HHL as substrate. This mixture was incubated for 30 min at 37°C. The reaction
was terminated with 1 mL of 1.75 M HCl. Hippuric acid released upon enzymatic
reaction was analyzed using high performance liquid chromatography. The analysis of
hippuric acid in samples was performed using a C18 (4.6 mm ID x 25 cm, particle size,
5 µm) (Supelco SIl LC-SI) attached with a guard column (12.5 mm analytical guard
column, Thermo Fisher Scientific Inc., CA, USA). The mobile phase consisted of an
isocratic system of 12.5% (v/v) methanol in HPLC grade water, flow rate was 0.3
mL/min, the run lasted for 9 min and the temperature of the column oven was adjusted
at 20°C. Detection was carried with UV–Vis photodiode array detector at a wavelength
of 228 nm. Samples 5 µL were injected onto the HPLC system. Standard calibration
curve was created with different hippuric acid concentration solubilized in sodium
borate buffer (1-1000 µg/mL). The data collected was processed by the Chromeleon
6.8 Chromatography Data System (Dionex Corporation 1228 Titan Way, Sunnyvale,
CA, USA).
The percent inhibition of enzyme activity was calculated as follows:
𝐻𝑖𝑝𝑝𝑢𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)−𝐻𝑖𝑝𝑝𝑢𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑡𝑒𝑠𝑡)

% ACE inhibition = (

𝐻𝑖𝑝𝑝𝑢𝑟𝑖𝑐 𝑎𝑐𝑖𝑑 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)

) x 100
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3.6.4 Antidiabetic Activity
3.6.4.1 α- Glucosidase Inhibition
α-glucosidase inhibition was assessed according to the method reported by
Zhang et al. (2011) with minor modifications. Approximately 80 μL of whey
hydrolysate samples was added to 100 μL of 4-nitrophenyl-β-D-glucuronide (10 mM
PNPG dissolved in 0.1 M sodium phosphate buffer, pH 6.8). The reaction was initiated
by addition of 20 μL enzyme solution (1 U/mL) followed by 10 min incubation at 37°C
Then, 200 μL of the reaction mixture was taken and transferred to a 96-well plate. To
measure the release of p-nitrophenol from PNPG, the absorbance was read at 405 nm
by microplate reader (Epoch 2, BioTek, VT, USA). Triplicate measurements for each
sample were carried out. α-glucosidase inhibition (%) was calculated using the
following equationα-glucosidase inhibition % = [ 1- {

𝐴(𝑠𝑎𝑚𝑝𝑙𝑒)−𝐴(𝑏𝑙𝑎𝑛𝑘)
𝐴(𝑡𝑒𝑠𝑡)−𝐴(𝑐𝑜𝑛𝑡𝑟𝑜𝑙)

} ] * 100

where, A(sample) = absorbance of the mixture of whey sample, PNPG solution and
enzyme,
A(blank) = absorbance of the mixture of whey sample and PNPG solution without
enzyme,
A(test) = absorbance of the mixture of buffer (instead of sample), PNPG solution and
enzyme and
A(control) = absorbance of the mixture of buffer and PNPG solution without enzyme
3.6.4.2 α- Amylase Inhibition
α-amylase inhibition was measured according to the method described by
Chinedum et al. (2018). Approximately 40 μL of whey hydrolysate sample was diluted
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with 160 μL of distilled water and mixed with 400 μL of 4% starch solution in a
centrifuge tube. Next, 200 μL of the enzyme solution (30 unit/ml) was added and
incubated at 25°C for 3 minutes. From this mixture, 200 μL was taken and added into
a separate tube containing 100 μL 3,5- dinitrosalicylic acid (DNS) color reagent
solution (96 mM DNS; dissolved in 5.31 M of potassium tartarate in 2 M NaOH). The
reaction was terminated by incubating at 95°C for 10 minutes. Then, 900 μL of
distilled water was added, and the mixture was vortexed. To a 96-well plate, 200 μL
of the reaction mixture was added, and the absorbance was read at 540 nm using a
microplate reader (Epoch 2, BioTek, VT, USA). The experiment was carried out in
triplicates and α-amylase inhibition % was calculated as followsα-amylase inhibition % = [ 1- {

𝐴(𝑠𝑎𝑚𝑝𝑙𝑒)−𝐴(𝑏𝑙𝑎𝑛𝑘)
𝐴(𝑡𝑒𝑠𝑡)−𝐴(𝑐𝑜𝑛𝑡𝑟𝑜𝑙)

} ] * 100

where A(sample) = absorbance of the mixture of whey sample, starch solution, enzyme
and DNS color reagent solution,
A(blank) = absorbance of the mixture of whey sample, starch solution and DNS color
reagent without enzyme,
A(test) = absorbance of the mixture of buffer (instead of sample), starch solution,
enzyme and DNS color reagent,
A(control) = absorbance of the mixture of buffer, starch solution and DNS color
reagent without enzyme
3.6.4.3 DPP-IV Inhibition
DPP-IV inhibitory activity was measured using the method described by
Lacroix and Li-Chan (2013). About 25 μL of 1 mM Gly-Pro-p-nitroanilide (substrate),
50 μL DPP-IV (10 U/mg), 100 μL of 0.1 M Tris-HCl buffer (pH 8.0), and whey
samples (50 and 100 μL) were added and incubated for 90 minutes at 37°C. The
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reaction was terminated by adding 100 μL of 1 M sodium acetate buffer (pH 4.0). The
absorbance of the released p-nitroanilide was read at 405 nm using a microplate reader
(Epoch 2, BioTek, VT, USA). Each sample was analyzed in triplicate, and sample
blanks were included where Tris-HCl buffer was replaced with DPP-IV. Tris-HCl
buffer was used as negative control and positive control was prepared with DPP-IV
solution instead of sample. The DPP-IV inhibition rate was calculated as:
A(sample)−A (sample blank)

% DPP-IV inhibition = (1- A (positive control)−A (negative control) ) x 100
where A (sample) = absorbance of the mixture of whey sample, substrate, DPP-IV
enzyme and Tris-HCl buffer
A (blank) = absorbance of the mixture of whey sample, substrate and Tris-HCl buffer
without enzyme
A (positive control) = absorbance of the mixture of substrate, DPP-IV enzyme and
Tris-HCl buffer,
A (negative control) = absorbance of the mixture of substrate, and Tris-HCl buffer
without enzyme and whey sample
3.6.5 Lipase Inhibition Activity
The lipase inhibition assay was conducted as per the method described by
Badmaev et al. (2015) with some modifications. The reagents prepared were Tris
buffer A 100 mM/L Tris-HCl (pH 6.8), 5 mM/L CaCl2, and 1 mM/L disodium salt of
ethylenediaminetetraacetic acid (Na2EDTA). About 10 mM/L of 3-(N-morpholino)
propansulfonic acid (MOPS) solution was added to porcine pancreatic lipase (EC
3.1.1.3, Sigma) to make the concentration 1000 U/mL. For the enzyme solution, 850
μL of Tris buffer was added to 30 μL of porcine pancreatic lipase solution, while for
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the substrate solution, N, N-dimethylformamide was added to 4-nitrophenyl butyrate
to make the concentration as 40 mM/L. Finally, the test article solution was prepared
by mixing N, N-dimethylformamide and Tris buffer at a ratio of 1:4. Then, 100 μL of
sample and 880 μL of enzyme solution was added to the microplate and incubated at
37°C for 15 min. Following this, 20 μL of substrate solution was added to start the
enzymatic reaction at 37°C. The absorbance was measured at 405 nm every minute for
15 min using microplate reader (Epoch 2, BioTek, VT, USA). The experiment was
performed in triplicates. The percentage of lipase inhibition was calculated by the
following equation:
% Lipase inhibition = [1 – (B – b) / (A – a)] x 100
where, A is the activity in the absence of the inhibitor; a is the negative control in the
absence of inhibitor; B is the activity in the presence of the inhibitor; and b is the
negative control in the presence of the inhibitor.
3.6.6 Cholesterol Esterase Inhibition Activity
The pancreatic cholesterol esterase inhibition was assayed using a modified
method as described by Myers et al. (1955). CWPHs (50 µL) was incubated with
substrate mixture (100 µL) containing 5.16 mM taurocholic acid, 2 mM cholesteryl
acetate in 100 mM sodium phosphate buffer, and 100 mM NaCl. The reaction was
initiated by adding 100 µL of porcine pancreatic cholesterol esterase (5 μg/mL). After
incubation for 30 min at 37°C, the reaction was terminated by addition of 1M HCl.
Cholesterol released upon enzymatic hydrolysis of cholesteryl acetate was extracted
three times using hexane and was determined by using reverse-phase high performance
liquid chromatography (RP-HPLC) (Thermoscientific dionex ultimate 3000,
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Germering, Germany) following the method described by Prates et al. (2006) with
modification. The analysis of cholesterol in samples were performed using a normalphase silica column (4.6 mm ID x 25 cm, particle size, 5 µm) (SUPELCOSIL LC-Si)
attached with a guard column (12.5 mm analytical guard column, Thermo Fisher
Scientific Inc., CA, USA). The mobile phase consisted of 1% (v/v) isopropanol in nhexane, flow rate was 1 mL/min, the run lasted for 7 min and the temperature of the
column oven was adjusted at 20°C. Detection was carried with UV–Vis photodiode
array detector at a wavelength of 202 nm. Samples (5 to 10 µL) were injected onto the
HPLC system. Standard calibration curve was generated with different cholesterol
concentration solubilized in hexane. The data was collected and processed by the
Chromeleon® Chromatography Data System 7.0 (Dionex UltiMate 3000 RS Diode
Array detector) included in the HPLC system. The percent inhibition of enzyme
activity was calculated as follows:
% Cholesterol esterase inhibition =

𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑡𝑒𝑠𝑡
𝑐𝑜𝑛𝑡𝑟𝑜𝑙

* 100

3.7 Statistical Analysis
Camel whey proteins prepared from milk of female camels was pooled together
and hydrolyzed separately to produce three different sets of hydrolysates for each
enzyme tested, which served as three replicates. The data were subjected to one-way
analysis of variance (ANOVA) using SPSS 12.0 software (SPSS INC., Chicago, IL,
USA,2002). Signiﬁcant treatment means were separated by Duncan’s New Multiple
Range Test.
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Chapter 4: Results
4.1 Characterization of Camel Whey Protein Hydrolysates
4.1.1 Degree of Hydrolysis (DH)
Degree of hydrolysis (DH) of camel whey protein hydrolysates were expressed
in terms of percentage (%) of hydrolysis carried out by each enzyme on the protein
substrate as shown in Figure 1.
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Figure 1: Degree of hydrolysis (DH) % of camel whey protein hydrolysates produced
by gastric and pancreatic enzymes after 3 and 6 h of hydrolysis. Keynotes: P3pepsin (3h), P6- pepsin (6h), C3- chymotrypsin (3h), C6- chymotrypsin (6h), T3trypsin (3h), T6- trypsin (6h). Data represent mean ± SD (n = 3). Different lowercase
letters indicate significant differences (P < 0.05) among the hydrolysates

DH of camel whey proteins varied from 8.54% to 47.53%, with chymotrypsin
(C6) derived hydrolysates displaying the highest DH (47.53% ± 7.7), and trypsin (T3)
derived hydrolysates showing the lowest DH (8.54% ± 0.94). DH for each enzyme
increased with increase in time of hydrolysis from 3 to 6 hrs. It was observed that at 3
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h, all enzymes produced peptides with similar degree of hydrolysis (~10%) with no
significant difference between them (P > 0.05). Further hydrolysis (i.e. up to 6 h)
resulted in an increase of DH (%) for all 3 enzyme-generated hydrolysates. There was
a one-fold increase in DH for peptic hydrolysates and nearly a two-fold increase for
chymotryptic hydrolysates. Chymotrypsin (C6) produced hydrolysates depicted
47.53% ± 7.7 DH, followed by pepsin (P6) (24.58% ± 3.67) and trypsin (T6) (14.49%
± 0.88) produced hydrolysates after 6 h of hydrolysis.
4.1.2 RP-HPLC
HPLC chromatogram of camel whey and camel whey protein hydrolysates
(CWPHs) generated pepsin, trypsin and chymotrypsin after 3 and 6 h is shown in
Figure 2. In the intact camel whey proteins (W), an intact peak belonging to α-LA was
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Figure 2: Reversed-phase high performance liquid chromatography (RP-HPLC)
profile of camel whey and camel whey protein hydrolysates produced by pepsin,
trypsin and chymotrypsin after 3 and 6 h of hydrolysis. Key notes: W- intact camel
whey proteins, P3- pepsin (3h), P6- pepsin (6h), C3- chymotrypsin (3h), C6chymotrypsin (6h), T3- trypsin (3h), T6- trypsin (6h).
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Upon hydrolysis, clear small peaks were seen for all six hydrolysates between
the retention time 2.5 – 4.6 minutes, which were generated due to the complete
degradation of α-LA. These peaks represented the shorter peptides which were
produced following enzymatic digestion. Higher degree of hydrolysis with generation
of intense smaller peptides distributed over a wide range of hydrophobicity and
molecular weight was observed in chymotrypsin (C3 & C6) and pepsin (P3 & P6)
generated CWPHs, which was also reflected by the DH results (Figure 1), where
chymotrypsin and pepsin displayed a higher DH than trypsin generated hydrolysates
at 6 h. On the other hand, trypsin (T3 & T6) showed some traces of α-LA, as well as
lesser amounts of small peptides (Figure 2). Thus, trypsin derived CWPHs displayed
less intense shorter peptide peaks which were distributed within a narrow range of
hydrophobicity. Overall, chymotrypsin derived CWPHs showed highest detector
response for the shorter peptide peaks, followed by pepsin and trypsin CWPHs.

4.2 Antioxidant Activity of Camel Whey Protein Hydrolysates
4.2.1 DPPH Radical Scavenging Activity
The DPPH radical scavenging activity of camel whey protein and its
hydrolysates is depicted in Figure 3. The results showed that different CWPHs
generated with different enzymes demonstrated different radical scavenging potential.
Hydrolysates from chymotrypsin had the highest scavenging activity followed by
trypsin (P < 0.05). Chymotrypsin derived CWPHs showed a significant increase in
scavenging activity from 3 to 6 h (415.5 ± 1.16 and 618.59 ± 0.89 μmol TE/g of
sample, respectively) (P < 0.05).
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Figure 3: DPPH radical scavenging activity (μmol of trolox equivalents (TE)/g) of
camel whey protein (W) and camel whey protein hydrolysates (CWPHs) produced
by pepsin, chymotrypsin and trypsin after 3 and 6 h of hydrolysis. Data represent
mean ± SD (n = 3). Different letters (a–d) above bars represent a significant
difference (P < 0.05) among different CWPHs.

In contrast, antioxidant effects of trypsin hydrolysates decreased after 6 h (from
396.7 ± 0.35 μmol TE/g of sample to 324.5 ± 1.21 μmol TE/g of sample). Pepsin
generated hydrolysates also didn’t show any major increase in their scavenging
activity. However, hydrolysates from both chymotrypsin and trypsin exhibited higher
DPPH radical scavenging activity than the unhydrolyzed whey (W). Overall,
chymotrypsin generated CWPHs displayed higher and pepsin derived CWPHs had
lowest scavenging activities (P < 0.05).
4.2.2 ABTS Radical Scavenging Activity
ABTS radical scavenging activity displayed by camel whey proteins and its
hydrolysates is depicted in Figure 4. Intact whey protein had the lowest ABTS
scavenging activity (7.1 ± 0.32 μmol TE/g of sample). After hydrolysis, all CWPHs
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proved to be efficient scavengers of ABTS radical (P < 0.05). Most efficient were the
hydrolysates from chymotrypsin (84.5 ± 0.11 μmol TE/g of sample) with no significant
difference when the hydrolysis time increased from 3 to 6 h (P > 0.05).
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Figure 4: ABTS radical scavenging activity (μmol of trolox equivalents (TE)/g) of
camel whey protein (W) and camel whey protein hydrolysates (CWPHs) produced
by pepsin, chymotrypsin and trypsin after 3 and 6 h of hydrolysis. Data represent
mean ± SD (n = 3). Different letters (a–d) above bars represent a significant
difference (P < 0.05) among different CWPHs.

Trypsin generated CWPHs were the second most effective hydrolysates with
69.8 ± 0.19 μmol TE/g of sample of ABTS radical scavenging activity at 3 h, and a
one-fold increase was observed at 6 h (79.2 ± 0.13 μmol TE/g of sample). Lowest
ABTS radical scavenging activity among the hydrolysates, were found in the pepsin
generated CWPHs which increased from 3 h (22.9 ± 0.34 μmol TE/g of sample) to 6
h (26.4 ± 0.92 μmol TE/g of sample) of hydrolysis time. Overall, all enzyme generated
CWPHs had higher ABTS radical scavenging activity when compared to intact camel
whey proteins, with chymotrypsin hydrolysates showing the highest activity and
pepsin hydrolysates showing the lowest.
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4.2.3 Ferric Reducing Antioxidant Power (FRAP) Assay
The FRAP assay was carried out on camel whey protein and its hydrolysates,
and results are graphically represented in Figure 5. The reducing power varied
significantly between all camel whey protein hydrolysates (CWPHs) and intact camel
whey protein (W) (P < 0.05).
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Figure 5: Ferric-reducing antioxidant power (FRAP) (μmol of trolox equivalents
(TE)/g) of camel whey protein (W) and camel whey protein hydrolysates (CWPHs)
produced by pepsin, chymotrypsin and trypsin after 3 and 6 h of hydrolysis. Data
represent mean ± SD (n = 3) from 3 replicates. Different letters (a–d) above bars
represent a significant difference (P < 0.05) among different CWPHs.

Compared to intact camel whey, only pepsin hydrolysates had slight
improvement in their reducing power at 3 and 6 h (550.6 ± 9.51 μmol TE/g of sample)
(P < 0.05). The hydrolysates from chymotrypsin and trypsin showed no increase in
reducing power than intact camel whey. In fact, tryptic hydrolysates displayed very
poor reducing power even at longer hydrolysis time (422.4 ± 8.71 μmol TE/g of
sample), when compared with camel whey. Although pepsin hydrolysates had
significant activity, overall, there was no enhancement in reducing power for any of
the hydrolysates from three enzymes when compared to camel whey protein.
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4.2.4 Ferrous Ion Chelating Activity
Ferrous ion chelation activity of camel whey protein and its hydrolysates is
presented in Figure 6. There was a significant increase in the chelating activity
displayed by camel whey protein hydrolysates after hydrolysis (P < 0.05). Ferrous ion
chelating activity increased for trypsin derived hydrolysates with hydrolysis time from
3 to 6 h (52.1% to 65.3%, respectively) (P < 0.05), while pepsin (P3) and chymotrypsin
(C3, C6) hydrolysates didn’t show significant difference in their chelating activity (P
> 0.05). Trypsin generated hydrolysates after 6h was able to increase the metal
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Figure 6: Ferrous ion-chelating activity (%) of camel whey protein (W) and camel
whey protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin
after 3 and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates.
Different letters (a–d) above bars represent a significant difference (P < 0.05) among
different CWPHs.

It was observed that the chelating activity for CWPHs from pepsin decreased
to 20% after 6 h. Intact camel whey (W) showed 14.8% chelation of ferrous ions. Thus,
trypsin derived CWPHs had the highest ferrous ion chelating activity, while pepsin
derived CWPHs at 6 h had the lowest activity among the hydrolysates produced.
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4.3 Antimicrobial Activity of Camel Whey Protein Hydrolysates
The antimicrobial activity of camel whey protein and its hydrolysates against
2 Gram-positive and 3 Gram-negative bacteria is given in Table 4. For Cronobacter
sakazakii, the inhibition % varied from 22.42% ± 0.39 to 51.59% ± 0.72. The highest
antimicrobial activity was shown by both pepsin and trypsin hydrolysates at 6 h (P >
0.05). Pepsin (P3) derived CWPHs had 41.98% ± 0.59 growth inhibition activity which
increased to 51.59% ± 0.72 after 6 h of hydrolysis (P < 0.05). Similarly, an increase in
antimicrobial activity was seen for trypsin hydrolysates from 3 to 6 h (27.49% ± 0.85
to 49.62% ± 3.62). Although chymotrypsin hydrolysates showed good antimicrobial
activity, their activity decreased from 3 to 6 h of hydrolysis (from 46.72% ± 3.68 to
33.29% ± 0.46). For all CWPHs, the antimicrobial activity was enhanced in
comparison to intact whey. Hence, pepsin (P6) and trypsin (T6) derived CWPHs at 6
h of hydrolysis time demonstrated the highest antimicrobial activity, while trypsin (T3)
CWPHs showed the lowest at 3 h.
Like C. sakazakii, intact whey proteins and trypsin generated hydrolysate (6 h)
showed similar antimicrobial activity against Listeria monocytogenes (P > 0.05).
Among all the hydrolysates, pepsin generated hydrolysates had the highest
antimicrobial activity at 6 h (81.49% ± 2.05) against L. monocytogenes. Pepsin derived
CWPHs showed an increase in the antimicrobial activity from 3 to 6 h against L.
monocytogenes. The lowest activity was displayed by trypsin hydrolysates at 6 h
(29.95% ± 0.05), which was not significantly different to intact whey’s inhibition
activity (P > 0.05). Both trypsin and chymotrypsin generated CWPHs had a decrease
in inhibition activity towards L. monocytogenes with hydrolysis time (P < 0.05). When
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compared with whey, apart from trypsin hydrolysates (T6), all others showed
significantly enhanced antimicrobial activity (P < 0.05) against L. monocytogenes.

Table 4: Antimicrobial activity of camel whey protein (W) and camel whey protein
hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 and 6 h
of hydrolysis. Antimicrobial activity is measured in the form of growth inhibition %.
Data represent mean ± SD (n = 3) from 3 replicates.

Samples

Growth inhibition %
Cronobacter
sakazakii

Listeria
monocytogenes

Staphylococcus
aureus

Escherichia
coli

Salmonella
typhimurium

W

22.42 ± 0.39 a

30.21 ± 9.59 a

7.07 ± 0.35 a

9.42 ± 0.84 a

3.47 ± 0.21 a

P3

41.98 ± 0.59 c

75.54 ± 0.10 de

64.94 ± 3.40 c

10.55 ± 1.12 a

45.73 ± 4.36 e

P6

51.59 ± 0.72 d

81.49 ± 2.05 e

65.0 ± 0.35 c

40.41 ± 4.62 c

50.1 ± 1.30 e

C3

46.72 ± 3.68 cd

65.42 ± 0.10 cd

48.93 ± 1.61 b

19.17 ± 1.19 ab

25.87 ± 4.87 cd

C6

33.29 ± 0.46 b

52.87 ± 5.58 bc

48.34 ± 3.28 b

17.42 ± 5.46 ab

26.82 ± 5.96 d

T3

27.49 ± 0.85 a

45.28 ± 4.11 b

6.18 ± 3.04 a

59.41 ± 6.23 d

15.54 ± 5.60 bc

T6

49.62 ± 3.62 d

29.95 ± 0.05 a

13.34 ± 3.88 a

27.16 ± 1.33 b

5.94 ± 0.21 ab

Different lowercase letters in the columns indicate significant differences (P < 0.05)
among the hydrolysates.

For Staphylococcus aureus, highest antimicrobial activity was depicted by
pepsin derived CWPHs, followed by chymotrypsin and trypsin (P < 0.05). There was
no significant difference observed within each hydrolysate and its hydrolysis time i.e.
pepsin hydrolysates at 3 and 6 h had similar inhibition % (~65.0% ± 0.35), as did
chymotrypsin (~48.93% ± 1.61) and trypsin (13.34% ± 3.88) at both hydrolysis times.
Hence, the antimicrobial activity against S. aureus did not increase or decrease with
hydrolysis time (P > 0.05) for all the CWPHs. However, trypsin generated
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hydrolysates showed antimicrobial activity similar to the intact camel whey proteins
(W) (P > 0.05). Thus, antimicrobial activity against S. aureus was highest for pepsin
hydrolysates and lowest for trypsin hydrolysates as well as intact whey proteins.
For Escherichia coli, trypsin generated hydrolysates showed the highest
antimicrobial activity after 3 h of hydrolysis (59.41% ± 6.23). In contrast,
antimicrobial activity of pepsin derived CWPHs at 3 h was the lowest (10.55% ± 1.12).
Inhibition activity of chymotrypsin generated hydrolysates against E. coli remained
the same at 3 and 6 h (P > 0.05), while for pepsin hydrolysates, it notably increased
from 3 to 6 h (P < 0.05). A decrease in growth inhibition % was seen in trypsin derived
CWPHs after 6 h (P < 0.05). Both intact whey protein and pepsin P3 hydrolysates (3
h) had no significant difference in their antimicrobial activity (P > 0.05). Overall,
highest antimicrobial activity against E. coli was demonstrated by trypsin (T3)
generated hydrolysates while lowest activity was shown by pepsin (P3) hydrolysates.
For Salmonella typhymurium, varied antimicrobial activity was observed.
Pepsin derived hydrolysates after 3 h of hydrolysis showed the highest inhibition %
(50.1% ± 1.30) with no improvement in antimicrobial activity after 6 h of hydrolysis
time (P > 0.05). Second best were CWPHs generated from chymotrypsin, which had
a very slight increase in % inhibition from 3 to 6 h (25.87% ± 4.87 to 26.82% ± 5.96).
The least antimicrobial activity against S. typhymurium was shown by trypsin derived
CWPHs after 3 h of hydrolysis (15.54% ± 5.60), which further decreased after 6 h of
hydrolysis (5.94% ± 0.21) (P < 0.05). In comparison to all the hydrolysates, intact
whey had the lowest activity (3.47% ± 0.21). Thus, after the hydrolysis process, the
antimicrobial activity against S. typhymurium was enhanced for all hydrolysates;
highest for pepsin and lowest for trypsin derived CWPHs.
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4.4 Antihypertensive Activity of Camel Whey Protein Hydrolysates
ACE inhibitory activity of camel whey protein hydrolysates (CWPHs) is
shown in Figure 7. It was observed that the ACE inhibition values (%) displayed by
camel whey proteins and different hydrolysates varied from 19.4 % to 80.4 %.
Unhydrolyzed whey had very low ACE inhibition value (19.4% ± 0.15). However,
upon hydrolysis, the ACE inhibitory values significantly increased for all six CWPHs
in comparison to intact camel whey proteins (W) (P < 0.05). Among all CWPHs, ACEinhibitory activities of the pepsin and chymotrypsin generated hydrolysates after 3h of
hydrolysis were most efficient in comparison to other hydrolysates (P < 0.05), with
trypsin (T3) generated hydrolysates depicting the least inhibition. Pepsin (P3)
generated CWPHs after 3h of hydrolysis displayed highest ACE-inhibition activity
(80.4% ± 0.23) followed by chymotrypsin (C3) generated CWPHs (67.9% ± 3.67).
When hydrolysis time increased from 3 to 6 h, the ACE inhibition activity of both
pepsin and chymotrypsin-generated hydrolysates decreased to 60.26% ± 2.99 and
51.59 % ± 0.20 respectively (P < 0.05).
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Figure 7: ACE inhibition activity of camel whey protein (W) and camel whey protein
hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3 and 6 h
of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different
lowercase letters indicate significant differences (P < 0.05) among different CWPHs.
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Trypsin generated hydrolysates, on the other hand, showed an increased
inhibitory activity from 41.76 % ± 1.85 to 56.66% ± 1.85 when the hydrolysis time
increased from 3 to 6 h. Overall, pepsin hydrolysates (P3) had the highest inhibition
activity against ACE enzyme, while trypsin at 3 h had the lowest inhibition value
among all the hydrolysates.
4.5 Antidiabetic Activity of Camel Whey Protein Hydrolysates
4.5.1 DPP-IV Inhibitory Activity
DPP-IV inhibitory activities demonstrated by CWPHs generated by gastric and
intestinal enzymes after 3 and 6 h of hydrolysis is shown in Figure 8. The results
showed that DPP-IV inhibitory activity was significantly enhanced 3 to 4 times after
hydrolysis (P < 0.05). The inhibition activity for all 3 enzymes did not showed a
significantly difference with hydrolysis time (P > 0.05), except trypsin generated
hydrolysates, which increased from 3 to 6 h of hydrolysis time (P < 0.05).
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Figure 8: DPP-IV inhibition activity of camel whey protein (W) and camel whey
protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3
and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different
lowercase letters indicate significant differences (P < 0.05) among different CWPHs.
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Pepsin generated CWPHs at 3 h had the highest inhibition (93.4% ± 1.61) (P < 0.05),
while trypsin hydrolysates at 3 h had the lowest (65.31% ± 0.49). After 6 h of
hydrolysis, DPP-IV inhibition activity of pepsin and trypsin hydrolysates was
comparable with no significant differences in their activity (89.01% ± 3.84) (P > 0.05).
Also, chymotrypsin CWPHs activity didn’t show any change with hydrolysis time:
inhibition at both 3 and 6 h was 81.42% (P > 0.05). The DPP-IV inhibitory activity of
all CWPHs (65 to 93.4%) was significantly higher when compared to unhydrolyzed
camel whey (15% ± 3.64) (P < 0.05) demonstrating that the three enzyme hydrolysates
showed strong DPP-IV inhibitory activity.
4.5.2 α-Glucosidase Inhibitory Activity
Figure 9 shows the α-glucosidase inhibition demonstrated by CWPHs
generated by pepsin, trypsin and chymotrypsin after 3 and 6h of hydrolysis. It was
observed that the α-glucosidase inhibition activity of whey protein and its hydrolysates
varied from 24.5 % to 78.6 %. Pepsin (P3) and chymotrypsin (C3) generated CWPHs
had the highest α-glucosidase inhibition value (78.0%) at 3 h (P > 0.05). Conversely,
trypsin (T3) produced hydrolysates showed the lowest inhibition activity (24.5% ±
3.46). At 6 h of hydrolysis time, α-glucosidase inhibitory activity of both pepsin (P6)
and chymotrypsin (C6) generated hydrolysate decreased with no significant
differences between them (P > 0.05). On the other hand, tryptic hydrolysates’
inhibition activity increased with increase in hydrolysis time from 3 to 6 h (24.5% ±
3.46 to 38.2% ± 5.27).
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Figure 9: 𝛼-glucosidase inhibition activity of camel whey protein (W) and camel
whey protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin
after 3 and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates.
Different lowercase letters indicate significant differences (P < 0.05) among different
CWPHs.

When compared to the unhydrolyzed whey protein (44.7% ± 2.13), pepsin and
chymotrypsin generated hydrolysates showed higher inhibition. However, trypsin (T3)
derived CWPHs at 3 h had lower activity (24.5% ± 3.46), and similar activity at 6 h (P
> 0.05) when compared to the intact whey proteins. Overall, pepsin and chymotrypsin
CWPHs had highest α-glucosidase inhibition activity, whereas trypsin had the lowest.
4.5.3 α-Amylase Inhibitory Activity
CWPHs were also explored for their ability to act as an α-amylase inhibitor
that can retard the starch hydrolysis and production of glucose. Figure 10 shows αamylase inhibitory potential of camel whey proteins and CWPHs generated by gastric
and pancreatic enzymes.
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Figure 10: α-amylase inhibition activity of camel whey protein (W) and camel whey
protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3
and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different
lowercase letters indicate significant differences (P < 0.05) among different CWPHs.

α-amylase inhibition of the intact whey proteins displayed the least inhibition
(18.72% ± 3.81) compared to the CWPHs. All hydrolysates from the 3 enzymes
showed significant higher amylase inhibition activity, which increased with the
hydrolysis time. Indeed, at 3 h hydrolysis time, peptic CWPHs showed the highest αamylase inhibition (52.54% ± 2.72), followed by chymotrypsin (C3) (43.01% ± 5.46)
and trypsin (T3) generated CWPHs (30.72% ± 4.90) (P < 0.05). After 6 h of hydrolysis
time, the inhibition activity of chymotrypsin (C6) and pepsin (P6) generated
hydrolysates increased but was not significantly different among each other (P > 0.05).
Trypsin (T6) generated CWPHs inhibition activity also increased from 3 to 6 h but
compared to the other two hydrolysates (P6 and C6), it was the lowest at 6 h (57.45%
± 5.77) (P < 0.05). Thus, an increase in inhibition activity at 6 h was observed for
hydrolysates produced from all 3 enzymes. Overall, among the enzymes, hydrolysates
from chymotrypsin and pepsin at 6 h had highest amylase inhibition activity, while
trypsin generated hydrolysates at 3 h had the lowest activity.
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4.6 Anticholesterol Activity of Camel Whey Protein Hydrolysates
4.6.1 Cholesterol Esterase Inhibition Activity
Cholesterol esterase inhibition activity exhibited by CWPHs generated by
gastric and pancreatic enzymes is shown in Figure 11. When the hydrolysis was carried
for 3 h, only chymotryptic hydrolysate showed significant higher inhibition activity
(15.22% ± 0.07), compared to intact camel whey protein (W), peptic hydrolysate
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Figure 11: Cholesterol esterase inhibition activity of camel whey protein (W) and
camel whey protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and
trypsin after 3 and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3
replicates. Different lowercase letters indicate significant differences (P < 0.05)
among the hydrolysates.

However, after 6 h of hydrolysis time, peptic and tryptic derived CWPHs
displayed enhanced activity significantly which increased to 21.32% ± 0.34 and
17.92% ± 0.90, respectively (P < 0.05). Interestingly, chymotrypsin generated
hydrolysates after 6h of hydrolysis displayed no inhibition of cholesterol esterase at
all. Compared to control whey (4.3% ± 0.06), peptic hydrolysates at 3 h showed similar
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cholesterol esterase inhibition activity (3.73% ± 0.05) (P > 0.05), while both
chymotrypsin (C6) and trypsin (T3) derived hydrolysates showed a significantly lower
inhibitory activity than intact whey proteins (W) (Figure 11). Overall, highest
cholesterol-esterase inhibition activity was observed for pepsin CWPHs (P6), trypsin
(T6) and to less extent chymotrypsin (C3) hydrolysates.
4.6.2 Lipase Inhibition Activity
Inhibition of pancreatic lipase activity by camel whey intact proteins and
CWPHs is shown in Figure 12. Lipase inhibition activity was significantly enhanced
upon hydrolysis for all hydrolysates when compared to intact camel whey proteins (W)
(P < 0.05). Peptic hydrolysates (P3) showed highest lipase inhibitory activity (49.76%
± 4.62) when compared to the other two enzymes. Chymotryptic (C3) (48.35% ± 1.87)
and tryptic (T3) hydrolysates (34.89% ± 4.23) at 3 h were not far behind the pepsin
generated CWPHs (P < 0.05).
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Figure 12: Lipase inhibition activity of camel whey protein (W) and camel whey
protein hydrolysates (CWPHs) produced by pepsin, chymotrypsin and trypsin after 3
and 6 h of hydrolysis. Data represent mean ± SD (n = 3) from 3 replicates. Different
lowercase letters indicate significant differences (P < 0.05) among different
hydrolysates.
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With an increase in hydrolysis time from 3 to 6 h, pepsin (P6) derived CWPHs
displayed no significant difference in lipase inhibitory activity (P > 0.05). In contrast,
decrease in inhibition activity was seen for the chymotrypsin (C6) and trypsin (T6)
generated hydrolysates at 6 h (P > 0.05). Overall, all the hydrolysates exerted a higher
lipase inhibitory activity in contrast to intact whey which demonstrated 15.33% ± 2.98
inhibition of lipase activity. Thus, among the hydrolysates, pepsin (both P3 and P6)
and trypsin (T6) derived CWPHs had the highest and lowest lipase inhibitory activity,
respectively.
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Chapter 5: Discussion
5.1 Characterization of Camel Whey Protein Hydrolysates
Application of protein hydrolysates in new food product development requires
prior characterization of the hydrolysates produced. One way to characterize
hydrolysates is through degree of hydrolysis (DH) which calculates the percentage of
peptide bond breakdown in the native protein (Wang & Wang, 2001). This breakdown
or hydrolysis process is the key way in which major proteins are degraded to release
small peptides and free amino acids which are known to contribute in enhancing the
functional and bioactive properties of food proteins (Cheison et al., 2009; Le Maux et
al., 2016). Thus, DH is an important parameter which explains the effects and the
scope of protein hydrolysis (Cheison et al., 2009).
The enzymatic hydrolysis of camel whey protein by all 3 enzymes, in general,
depicted an increase in DH with hydrolysis time (Figure 1). Chymotrypsin-generated
hydrolysates had the highest DH after 6h, suggesting that in comparison to other
enzymes, chymotrypsin enzyme was more efficient in its proteolytic activity. Similar
results were reported by Salami et al. (2008) where camel milk casein was more
susceptible to chymotrypsin hydrolysis than bovine casein.
The differences in DH (%) among the hydrolysates produced could be
attributed to enzyme reaction rate, enzyme specificity and substrate affinity (Dryakova
et al., 2010). Consequently, the amino acid sequence of the resultant hydrolysates
would also be different, since all 3 enzymes cleave at different sites - chymotrypsin
cleaves peptide bond next to aromatic amino acids like Phe, Tyr, Trp (López-Fandiño
et al., 2006), trypsin acts at carboxyl side of amino acids arginine or lysine, while
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pepsin prefers aromatic residues (Tavano, 2013). Moreover, the extent of DH value
reflects the content of shorter peptides liberated - higher the DH, higher is the content
of released amino groups or shorter peptides liberated (Morais et al., 2005).
A kinetic characterization study revealed that caseins are more readily
hydrolyzed than whey counterparts due to their open tertiary structure, more flexibility
and presence of prolyl residues (Damodaran 1994; Qi et al., 2003; Mizuno et al., 2004
as cited in Salami et al., 2008). On the other hand, whey protein’s compact and
globular structure makes it less susceptible to digestion. For this reason, whey protein’s
enzymatic hydrolysis was carried out for a longer time (6 h) to achieve maximum
degradation (Salami et al., 2008). Thus, in the present study, although a low DH at 3
h for whey hydrolysates was seen, further hydrolysis produced a greater DH (%) for
all three enzymes (Figure 1).
Another way to characterize and monitor the production of shorter peptides
(usually represented as short peaks) from milk proteins is RP-HPLC which was
performed in the present study (Figure 2). Since RP-HPLC works on the principle of
separation of molecules based on hydrophobicity, hydrophobic molecules in the polar
mobile phase tend to adsorb to the stationary phase, while hydrophilic molecules in
the mobile phase pass through the column and are eluted first (Wall et al., 2000;
Sharma, 2014). This indicates that chymotrypsin and pepsin generated hydrolysates
possessed higher hydrophilic peptides as compared to trypsin, since their elution was
earlier to that of trypsin generated hydrolysates. Also, chymotrypsin derived
hydrolysates had the highest detector response for the short peptide peaks, followed
by pepsin and trypsin hydrolysates. which supports our DH (%) results where
chymotrypsin (C6) hydrolysates displayed highest DH (%) (Figure 1).
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Prior to hydrolysis, camel whey protein contained α-LA as the major protein,
as indicated by a single sharp peak (Figure 2). Indeed α-LA is the major protein in
camel whey as reported in many studies (Farah, 1986; Farah & Atkins, 1992; Laleye
et al., 2008; Berhe et al., 2017). Upon hydrolysis, none of the six hydrolysates showed
a prominent peak of α-LA which suggests that almost complete degradation of α-LA
was carried out by the enzymes. Hence, all three digestive enzymes were efficient in
breaking down the camel whey protein and producing shorter peptides at different
degrees.
5.2 Antioxidant Activity
The mechanisms through which peptides in the protein hydrolysates show their
antioxidant activity is by radical-scavenging, reducing power, inhibition of lipid
peroxides, chelation of metal ions, or a combination of these (Sarmadi & Ismail, 2010).
Thus, it is necessary to substantiate the antioxidant capacity of the bioactive
compounds by examining them through different antioxidant assays, since the
mechanism of action is different in different assays (Alam et al., 2013). For this reason,
four in vitro test procedures were carried out to evaluate the antioxidant activities of
camel whey protein hydrolysates.
An example of a free radical is DPPH, whose scavenging activity indicates the
antioxidant potential of a compound (Power et al., 2013). Camel whey protein and its
hydrolysates were tested for their DPPH radical scavenging activity (Figure 3). It was
observed that chymotrypsin generated CWPHs were most efficient at scavenging
DPPH radicals, thus having a positive relationship between hydrolysis time and DPPH
activity (Kumar et al., 2016a). Similar results were reported by Salami et al. (2010)
where chymotrypsin derived bovine and camel whey protein hydrolysates displayed
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higher radical scavenging activity compared to tryptic hydrolysates. It is known that
chymotrypsin enzyme favors cleavage at carboxylic side of aromatic side chains and
produces peptides with amino acids at C-terminal position having antioxidant potential
(Pihlanto, 2006). Hence, the results of present study as well as previous reports suggest
that for peptides to show good antioxidant properties, amino acids at C-terminal
residues have a critical role in showing antioxidant potential. Similarly, Conway et al.
(2012) proposed that peptides originating from major whey proteins (α-LA and β-LG)
were likely responsible for the antioxidant activity. The antioxidant activity arises due
to specific amino acid residues present in the peptides, either because of their
capacities to donate protons to free radicals (Trp, Phe, Tyr, His, and Cys) or because
of their capacities to chelate metal cations (Glu, Asp, Lys, Arg, and His) (Elias et al.,
2006).
Trypsin-treated hydrolysates after 6 h showed a decrease in radical scavenging
activity. Furthermore, hydrolysates from pepsin performed poorly as they had the
lowest antioxidant activity compared to other two enzyme generated CWPHs as well
as intact whey. A recent study by Abd El-Fattah et al. (2017) also reported low DPPH
scavenging activity for trypsin treated bovine milk. The reason could be that structural
conformation of the peptide or the peptide bond itself could have decreased the
antioxidant activity. Since the sequence of amino acids in the hydrolysates is
dependent on the specificity of the protease, the lower activity of pepsin and trypsin
hydrolysates may have been due to the enzymes activity and peptides generated thereof
(Hernández-Ledesma et al., 2005). Hence, results of the present study agree that both
pepsin and trypsin generated CWPHs didn’t have strong antioxidant potential due to
reasons mentioned above.
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On the other hand, unhydrolyzed camel whey protein also displayed good
antioxidant activity. It has been suggested that both hydrolyzed and unhydrolyzed
camel milk proteins possess the ability to donate free electrons which interact with free
radicals, form stable molecules and stop the radical chain reaction (Kumar et al.,
2016a). Similar results were reported by Al Shamsi et al. (2018) where even native
camel milk protein displayed scavenging activity of DPPH radicals. Due to the
presence of certain amino acid residues like Phe, Trp, His, Tyr and Cys, the milk
proteins are capable of donating protons to free radicals, thus showing antioxidant
activity (Elias et al., 2008). Therefore, in the present study, camel whey protein
demonstrated some degree of antioxidant activity and upon hydrolysis, especially with
chymotrypsin, resulted in a six-fold increase in the DPPH radical scavenging activity.
ABTS was another free radical whose potential scavenging activity by
hydrolyzed and unhydrolyzed camel whey protein was measured (Figure 4). All
hydrolysates showed an increase in ABTS radical scavenging activity with progression
of hydrolysis time. Highest ABTS radical scavenging activity was demonstrated by
chymotrypsin treated hydrolysates, followed by trypsin- and pepsin-treated
hydrolysates. Kumar et al. (2016a) recorded increased scavenging activity of αchymotrypsin samples (P < 0.05), which was higher than alcalase and papain
hydrolysates. Kumar et al. (2016b) also reported similar results in their study of camel
casein hydrolysates. In addition, Salami et al. (2011) found that α-chymotrypsin
generated hydrolysates from camel whole casein had higher antioxidant activity than
pepsin and trypsin peptide fractions. They deduced that the C-terminal amino acids are
important in determining the antioxidant activity of a peptide fraction. Thus, results of
the present study are in accordance with the previous literature. The differences in the
antioxidative activity between the hydrolysates could be due to various factors like
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amino acid position, accessibility (Elias et al., 2005, 2008), sequence and presence of
hydrophobic/aromatic amino acids (Salami et al., 2011). Overall, our results revealed
that free radical scavenging activity of CWPHs improved significantly after
hydrolysis.
The third assay performed was the ferric reducing antioxidant power (FRAP)
assay which determines the reducing ability of an antioxidant from the ferric ion, ferric
2,4,6-tripyridyl-s-triazine complex [Fe(III)-(TPTZ)2]3+ to the blue colored [Fe(II)(TPTZ)2]2+ ferrous complex by donating an electron (Benzie & Strain 1996). The
reducing power of a compound can be used to assess its antioxidant activity potential
(Huang et al., 2004). The FRAP values of trypsin (T3, T6) and chymotrypsin (C6)
hydrolysates were less than that of intact camel whey proteins (Figure 5). Also, there
was no significant difference between FRAP values of intact camel whey protein and
chymotrypsin derived hydrolysates (C3) (P > 0.05). This was similar to results
obtained by Al-Shamsi et al. (2018) where unhydrolyzed camel whey had higher
FRAP values than hydrolysates produced by alcalase, papain and trypsin. Two
parameters play a vital role in determining the reducing power of protein hydrolysates:
(i) varying degree of hydrolysis, and (ii) enzymes used (Klompong et al., 2007). It is
possible that the differences in degree of hydrolysis produced peptides not capable of
reducing ferric iron (III) to ferrous iron (II). This could be why the hydrolysis process
didn’t have a significant effect on the reducing power of the CWPHs (Figure 5).
Furthermore, since the reducing power is directly correlated with peptide cleavages
(Cumby et al., 2008), it could be that trypsin and chymotrypsin enzyme specificity had
very less influence on enhancing the reducing power of the hydrolysates in the present
study.
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Our results show that the reducing power of pepsin generated hydrolysates was
somewhat improved in comparison to intact whey proteins (P < 0.05), but the FRAP
value was not greatly enhanced after hydrolysis. Thus, the resultant CWPHs from
pepsin showed marginal reducing power while those from trypsin and chymotrypsin
were not efficient at donating electrons.
Chelating activity is another important antioxidant potential in which the tested
compound demonstrates the capacity to chelate transition metal ions. Ferrous ions are
a type of metal ions that have been associated with cellular oxidative damage leading
to lipid peroxidation (Huang et al., 2002). Pepsin and chymotrypsin generated CWPHs
displayed similar chelating activity after 3 h of hydrolysis (P > 0.05), but at 6 h, activity
of peptic hydrolysates reduced (Figure 6). This reduction has been hypothesized to be
due to decreased peptide chain length, particularly at longer hydrolysis time. The study
by Je et al. (2009) on tuna liver protein and another study on sodium caseinate
hydrolysate (Luo et al., 2014) also reported a similar phenomenon where chelating
activities of hydrolysates produced at longer hydrolysis time decreased slightly. In
contrast, the chelating activity of trypsin generated hydrolysates after 6 h significantly
increased. It could be that trypsin mediated peptide cleavage caused a more
pronounced metal ion binding due to increased concentration of carboxylic groups in
the acidic and basic amino acid branches (Abd El-Fattah et al., 2017).
CWPHs produced by different enzymes displayed varied efficiency in
chelating iron. The differences in chelating activity has also been reported by Conway
et al. (2012) where whey concentrate’s sequential hydrolysis with pepsin and trypsin
displayed different levels of iron chelation. In the present study, chymotrypsin and
pepsin displayed higher degree of hydrolysis (Figure 1) but lower Fe2+ iron chelation
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activity compared to trypsin (Figure 6), suggesting that shorter peptides generated by
higher DH might lose their ability to complex with Fe2+ and chelate Fe2+.
Intact camel whey had the lowest activity in comparison to other samples, and
the activity was enhanced only after hydrolysis. The results can safely suggest that the
inactive peptide fragments trapped in the whey protein were released following
enzymatic hydrolysis and thus, improved the iron chelating activity of the camel whey
protein. Overall, the antioxidant activity status of CWPHs evaluated by different
methods shows that the extent of hydrolysis and the type of enzymes used are two
important factors that govern the release of encrypted inactive antioxidant peptide
sequences from the intact whey proteins.
5.3 Antimicrobial Activity
Antimicrobial activity of bioactive peptides is displayed by various
mechanisms such as prebiotic effect, peptides that are able to block attachment or
invasion of pathogen microorganism, or peptides that could induce a killing or
inhibiting effect on the growth of microorganism (Hernández-Ledesma et al., 2014).
Milk-derived antimicrobial peptides contain highly positive charged sequence. Thus,
the net positive charge may help in binding of the peptides to negatively charged
bacterial membranes. Also, the amphiphilic nature of peptides aids in bacterial
membrane disruption (Hernández-Ledesma et al., 2014).
To measure the antimicrobial efficacy of the camel whey protein and its
hydrolysates, growth inhibition (%) of 5 pathogenic bacteria - two Gram-positive
bacteria (L. monocytogenes, S. aureus) and three Gram-negative bacteria (E. coli, S.
typhymurium, C. sakazakii) was observed and values were recorded in Table 4.
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Overall, both intact camel whey proteins and hydrolyzed camel whey proteins
were capable of inhibiting growth of most of the pathogenic bacteria in this study.
Particularly, intact camel whey protein showed antimicrobial activity that was not
significantly different from the hydrolysates produced from trypsin (against C.
sakazakii, L. monocytogenes and S. aureus) and pepsin (against E. coli). Although the
activities were not very high, inhibition was still observed for intact whey protein
indicating that antimicrobial factors like lactoferrin, lysozyme, and immunoglobulins
naturally present in camel whey displayed effective antimicrobial activity (Salami et
al., 2010). This was also observed in a study by Jrad et al. (2014b) where camel milk
whey protein exhibited a greater growth-reducing effect on E. coli than bovine whey
protein. Subsequent treatment of camel whey proteins with proteases like trypsin,
chymotrypsin and proteinase K gave hydrolysates with three-fold increase in their
antibacterial activities (Salami et al., 2010). In the present study too, enhanced
antimicrobial activities is shown for nearly all CWPHs derived from pepsin, trypsin
and chymotrypsin when compared to non-hydrolyzed whey protein.

Both pepsin and trypsin hydrolysates against C. sakazakii had a higher
inhibition activity at 6 h, while activity against C. sakazakii displayed by chymotrypsin
generated CWPHs decreased at the same time. L. monocytogenes, an important
pathogenic bacterium that is found in contaminated raw and processed meat products,
was also inhibited by the CWPHs. Pepsin generated hydrolysates showed highest and
increased activity with hydrolysis time, whereas for other two enzymes, inhibition
activity decreased at 6 h. S. aureus was the only bacteria against which hydrolysates
showed improved antimicrobial activity than intact whey, but with no significant
increase or decrease in their activity from 3 to 6 h of hydrolysis. Growth inhibition (%)
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of E. coli and S. typhimuriumwas found to be highest by trypsin (T3) and pepsin (P3,
P6) derived CWPHs, respectively (Table 4).
Overall, amongst the enzymes, peptic hydrolysates were the best in displaying
antimicrobial activity by displaying growth inhibition (%) ranging from 10.55% ± 1.12
to 81.49% ± 2.05 against most bacteria. No set pattern between inhibition activity and
hydrolysis time was observed for tryptic and chymotryptic hydrolysates against the
five bacteria tested.
The differences in antimicrobial activity of hydrolysates produced with
different enzymes could be attributed to differences in the concentration, size and ionic
nature of pepides generated (Kumar et al., 2016b). Moreover, the efficacy of
antimicrobial activity relies on many factors like hydrophobicity (Kustanovich et al.,
2002), structural diversity (Gennaro & Zanetti, 2000), and presence of certain amino
acid residues like Arg, Pro, Cys, Gly, His (Andreu & Rivas, 1998). Synergistic effects
of different sized and charged peptides may be another reason for high antimicrobial
activity (Gobbetti et al., 2004). Overall, camel whey protein hydrolysates generated
with different enzymes displayed varied antimicrobial activities against different
pathogenic bacteria tested.
5.4 Antihypertensive Activity
ACE enzyme converts angiotensin I to angiotensin II, and increases the blood
pressure (Coates, 2003). Since hypertension is one of the many risk factors for
cardiovascular diseases, inhibiting ACE to control blood pressure is important.
Antihypertensive action of bioactive peptides can be due to competitive and/or noncompetitive inhibition of ACE. Competitive inhibition is competition of peptides with
ACE substrate for the enzyme active sites (Sato et al., 2002). Non-competitive (Leu-
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Trp, Ile-Tyr) and uncompetitive (Ile-Trp, Phe-Tyr) peptides are characterized by
peptides binding to other enzyme sites which changes enzyme conformation and
decreases activity. Thus, the interaction between peptides and ACE is greatly
influenced by a single amino acid substitution as well as isomers (Sato et al., 2002).
For this, structure-activity studies are vital to understand more (Udenigwe & Aluko,
2012). Other possible mechanisms of action include increase in activity of some
vasodilating agents like endothelial NOS, inhibition of renin (by mixed-type inhibition
mode), induction of vasodilation and reducing the activity of sympathetic system
(Aluko, 2015)
In the present study, intact camel whey’s ACE inhibition activity was 19.4%
(Figure 7). Previous studies have also reported very low ACE-inhibitory activity of
non-hydrolyzed bovine β-LG (<10%) (Mullally et al., 1997), and non-hydrolyzed
sheep cheese whey (12%) (Corrêa et al., 2014). This indicates that intact camel whey
proteins possessed higher ACE-inhibition activity when compared to whey proteins
from other species.
Figure 7 demonstrates very low ACE inhibition activity for native camel whey
proteins, but higher inhibition activity for the hydrolysates (42-80%). It can be
suggested that hydrolysis of inactive camel whey protein may release peptides with
potential ACE inhibitory activities. Similarly, camel whey hydrolysates produced by
pancreatic

enzymes

were

reported

to

possess

ACE-inhibitory

activity.

Antihypertensive tripeptide isoleucine-proline-proline (IPP) was identified and
quantified in digested camel milk (Tagliazucchi et al., 2016). Salami et al. (2011)
noted an increase in ACE inhibitory activities of camel whole casein and camel βcasein upon hydrolysis by trypsin and chymotrypsin. Tsuda and Miyamoto (2008) also
reported ACE inhibition activity of a purified peptide from fermented camel milk.
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Bovine whey studies have depicted similar results. Two highly potent ACE-inhibitory
peptides corresponding to α-LA and β-LG were identified from bovine whey protein
concentrate upon hydrolysis (Tavares et al., 2011). β-LG intact protein also
demonstrated very high ACE-inhibitory activity (73-90%) upon hydrolysis with
pepsin, trypsin, chymotrypsin and other proteases (Mullally et al., 1997), Proline,
tryptophan or tyrosine residues in the carboxyl terminal of the protein or peptide are
commonly associated with ACE-inhibition. When located at the C-terminal position,
proline has been recognized to be one of the most beneficial residues for peptide
binding to ACE’s active site. In the present study, the higher ACE inhibitory activity
was shown by pepsin generated CWPHs (Figure 7). Since pepsin is specific to
hydrophobic amino acids and α-LA contains a high amount of aromatic amino acid
residues in the C-terminal position, this would then assist the easy binding to ACE
(Otte et al., 2007). Therefore, it can be suggested that whey protein hydrolysates from
pepsin generated most potent ACE-inhibitory hydrolysates.
5.5 Antidiabetic Activity
Population studies have shown that consumption of camel milk was correlated
with low incidence of diabetes in Rajasthan (Agrawal et al., 2004a, 2005b). This was
attributed to a high content of lactoferrin, immunoglobulin, lactoperoxidase and
peptidoglycan in camel milk. It has been hypothesized that insulin-like protein in
camel milk helps maintain insulin secretory activity in pancreatic cells (Shori, 2015).
A recent cellular study by Abdulrahman et al. (2016) demonstrated camel milk’s
allosteric effect on human insulin receptor cells, which could have implications on the
hypoglycemic activity of camel milk, although further investigations at molecular
levels were recommended to confirm the findings. Other studies showing
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hypoglycemic activity of camel milk were performed on rats (Agrawal et al., 2004b,
2005a; Kamal et al., 2007), rabbits (El-Said et al., 2010) and dogs (Sboui et al., 2010a,
2010b).
Blood glucose regulation by bioactive peptides is mediated through different
mechanisms like insulinotropic activity, increased insulin secretion, effect on
metabolic enzymes involved in serum glucose modulation like DPP-IV, α-amylase,
and α-glucosidase (Lacroix & Li-Chan, 2014b). Insulinotropic effect is thought to be
due to the combination of bioactive peptides and branched chain amino acids
(Luhovyy et al., 2007; Morifuji et al., 2010). The free amino acids are reported to act
on pancreatic beta cells and promote insulin secretion by membrane depolarization,
mitochondrial signaling affecting insulin secretion etc. (Newsholme et al., 2010).
A serine exopeptidase, DPP-IV works by degrading and inactivating hormones
glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide
(GIP). These hormones are released upon food ingestion and increase insulin secretion.
By inhibiting DPP-IV, glycemic regulation in Type 2 diabetes can be improved
(Nongonierma & FitzGerald, 2017a). Inhibitors of the enzyme dipeptidyl-peptidase IV
(DPP-IV) are among the newest glucose-lowering drugs available in the market for
type 2 diabetes patients (Craddy et al., 2014). Apart from such synthetic drugs, some
studies have reported dietary proteins like milk, egg (Nongonierma & FitzGerald,
2014a) and fish (Huang et al., 2012) having peptide sequences that may inhibit DPPIV enzyme and could potentially complement drug therapy in regulating blood glucose
levels (Lacroix & Li-Chan 2012b, 2014b, 2016). Despite the knowledge that DPP-IV
inhibitory peptides can potentially be generated from various food proteins, only one
recent study has demonstrated DPP-IV inhibitory potential of camel milk protein
hydrolysates (Nongonierma et al., 2017c), while none have been performed on camel
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whey protein hydrolysates. In a recent study, camel milk protein tryptic hydrolysates
were reported to inhibit DPP-IV (Nongonierma et al., 2017c).
Our results suggested peptic hydrolysates to be the best DPP-IV inhibitors
(Figure 8). This was similar to in vitro simulated gastrointestinal digestion of whey
protein isolate by pepsin (78% of DPP-IV inhibition) in a study by Lacroix and LiChan (2013). A different study by Silveira et al. (2013) obtained a hydrolysate from
tryptic digestion of bovine whey protein concentrate which inhibited DPP-IV activity
(IC50 value of 1.51 mg/mL). In the present study, all three enzymes showed more than
50% inhibition which indicates that the enzymes released potent DPP-IV inhibitors.
Furthermore, enzyme specificity influences the DPP-IV inhibitory activity of the
produced hydrolysates (Brandelli et al., 2015). Lacroix et al. (2016) have reported
that bovine whey derived protein hydrolysates produced by Thermoase, Peptidase R
and ProteAX were able to inhibit ACE as well as DPP-IV enzymes at different degrees
of inhibition. Those hydrolysates which showed highest ACE-inhibitory activity did
not necessarily display higher DPP-IV inhibitory activity, indicating that active
peptides responsible for ACE and DPP-IV inhibitory activity might not be the same.
Studies show that peptides having proline or hydrophobic residues in their
sequence usually identify as DPP IV inhibitors (Lacroix & Li-Chan, 2012b). Also,
small size and hydrophobicity of these peptides may help in intestinal absorption and
display of their bioactivity (Nongonierma & FitzGerald, 2014b). The present study on
camel whey proteins hydrolysates and previous studies on bovine whey protein
hydrolysates demonstrate that gastric and intestinal enzymes like pepsin,
chymotrypsin and trypsin are the potential enzymes to generate hydrolysates with
potent DPP-IV inhibitory activities. This further indicates that camel whey proteins
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will most likely possess antidiabetic effect after gastric and intestinal digestion upon
consumption.
Another way to control type 2 diabetes is through inhibition of α-glucosidase.
This enzyme is responsible for digesting complex carbohydrates to simpler sugars and
thus increasing postprandial hyperglycemia (Kahn et al., 2014). It has been proposed
that peptides act as competitive inhibitors by binding to α-glucosidase enzyme’s active
site through hydrophobic interactions, thus retarding the absorption of glucose and
subsequently lowering the insulin levels (Bharatham et al., 2008; Patil et al., 2015).
This study presents for the first time the inhibitory potential of whey protein
hydrolysates towards α-glucosidase & α-amylase. Peptic (P3) and chymotryptic (C3)
hydrolysates at 3 h showed highest inhibition activity (Figure 9). A study by Lacroix
and Li-Chan (2013) reported that peptic hydrolysates of bovine whey protein isolate,
β-LG, and α-LA, at 2.5 mg/mL were able to inhibit α-glucosidase by 36, 33, and 24%,
respectively, whereas the non-hydrolyzed counterparts did not display any enzyme
inhibition. In comparison, the peptic hydrolysates in the present study showed
markedly high inhibition activity. These differences in the values could be because the
previous study used α-glucosidase from mammalian (rat) intestine while our source of
the enzyme was from baker’s yeast. It has been reported that the extent of αglucosidase inhibition greatly depends on the origin of enzyme. The structural
differences of the enzymes and their consequent altered binding sites could be a reason
for the variation in inhibition values (Oki et al., 1999; Kim et al., 2011)

It was also reported by Lacroix and Li-Chan (2013) that non-hydrolyzed
protein was not able to inhibit α-glucosidase enzyme. However, the native whey
protein in our study showed 45% inhibition. Findings from several studies on camel
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whey protein supplementation showed restoration of oxidative stress levels and
lowered blood insulin levels in diabetic rats (Ebaid et al., 2013), improvement of
wound healing in STZ-induced diabetic mouse model (Badr, 2013), and treatment of
immune impairment in type 1 diabetes rat model (Ebaid, 2014). Also, camel milk whey
protein is reported to be rich in half-cystine which is found to be superficially similar
to the peptides of insulin family (Beg et al., 1986). Hence, our results of camel whey
protein inhibiting α-glucosidase agree with previous studies. Trypsin derived
hydrolysates were not efficient at inhibiting α-glucosidase enzyme. It may be due to
the protein hydrolysates consisting of a mixture of peptides, and only some of these
peptides can show good activity. Thus, to achieve high potency, isolated peptides
would naturally be a better choice (Lacroix & Li-Chan, 2013). Since inhibition of αglucosidase is considered to be an effective strategy for the control of diabetes, the
results of the present study indicate that CWPHs which exhibit inhibitory activity up
to 78% towards α-glucosidase could be considered as potential antidiabetic agents

The third experiment carried out to explore indication of anti-diabetic effect of
CWPHs was α-amylase inhibition. This enzyme hydrolyses α-glycosidic bond on
polysaccharide such as glycogen and starch to produce glucose and maltose. α-amylase
activity inhibitors block dietary starch from being absorbed in the body causing
delayed digestion of carbohydrates, thus reducing glucose absorption rate and
postprandial blood glucose levels (Vankudre et al., 2015).
In general, hydrolysates from camel whey protein showed enhanced amylase
inhibition activity than intact whey proteins (Figure 10). Shori and Baba (2014)
reported a higher amylase inhibition activity (P < 0.05) in Allium sativum enriched
camel milk yogurt compared to bovine milk yogurt. Our results also concur that
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hydrolysis of camel whey protein releases peptide fragments that can inhibit amylase
enzyme. The inhibition is more potent when hydrolysis time is prolonged (Figure 10).
No study has previously reported α-amylase inhibitory properties of whey proteins and
their hydrolysates. Proteins from other than milk have been explored for α-amylase
inhibition. Pinto bean protein hydrolysates generated by protomex were reported to
have α-amylase inhibition activity (15.78 ± 1.70 to 52.08 ± 2.37 %) (Ngoh & Gan,
2016). Yu et al. (2012) studied the hydrolysis of egg albumin with alcalase, where
enhanced α-amylase inhibitory activity was displayed with IC50 value of 120 ± 4.0 and
110 ± 6.2 µmol l-1 for identified peptides KLPGF and EAGVD, respectively Thus,
CWPHs generated by the 3 enzymes in the present study showed an increased amylase
inhibition activity with increase in hydrolysis time. From the results of all three
inhibition tests, it can be suggested that hydrolysates from camel whey protein
demonstrated significant anti-diabetic effects. Thus, camel whey derived bioactive
peptides may help in glycemic management strategy, although further work is needed
to fully determine the bioavailability of the peptides in humans.
5.6 Anticholesterol Activity
An important risk factor in the pathogenesis of cardiovascular diseases,
particularly atherosclerosis, is hypercholesterolemia (Grundy et al., 1998). Bioactive
peptides have been demonstrated to decrease the levels of cholesterol. For instance,
Nagaoka et al. (2001) in their murine and Caco-2 cells study identified novel
hypocholesterolemic peptide lactostatin (Ile-Ile-Ala-Glu-Lys) from bovine β-LG
following trypsin hydrolysis. The results showed inhibition of micellar cholesterol
solubility, decreased cholesterol absorption and lower serum and liver cholesterol
levels in rats. Another study investigated β-lactotensin, a peptide isolated from bovine
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β-LG via chymotrypsin digestion (Yamauchi et al., 2003). They suggested that this
peptide stimulates bile acid secretion in rats, because of which hypocholesterolemic
activity was induced.
Camel milk is considered as a hypolipidemic agent, particularly in diabetic rat
models due to the presence of insulin-like protein and zinc that decrease the levels of
triglycerides (Agrawal et al., 2004b; Al Numair, 2010; Zuberu et al., 2017). Elayan et
al. (2010) found hypocholesterolemic effect of fermented camel milk (gariss) in dietinduced hypercholesterolemic rats. They reported that supplementation of 0.5 g for 6
weeks reduced the level of plasma total cholesterol, LDL-c and triglyceride with no
significant effect on HDL-c. The mechanism of milk derived hydrolysates showing
hypocholesterolemic activity is not well understood, but it is speculated that the
interaction between cholesterol and bioactive peptides leads to a decrease in
cholesterol levels (Li & Papadopoulos, 1998)
Our results agree with previous literature that native camel milk whey proteins
exhibited slight cholesterol-esterase inhibition (Figure 11). This means that camel
whey protein itself has antilipidemic effects. Hydrolysates derived from pepsin and
trypsin at 3 h had lower inhibition activity compared to intact whey proteins. However,
upon further hydrolysis, there was a sharp increase in cholesterol esterase inhibition
activity in peptic and tryptic hydrolysates. It might be because pepsin and trypsin
enzymes needed a longer hydrolysis time to expose the hypocholesterolemic peptide
fragments. On the contrary, chymotrypsin generated hydrolysates showed good
inhibition initially at 3 h of hydrolysis time, but longer hydrolysis time (6 h) gave
inhibition activity which was not detectable. It could be that extensive hydrolysis led
to production of even shorter peptides in chymotrypsin hydrolysates that were unable
to show their inhibition activity.

75
An important pancreatic enzyme is lipase which helps breakdown triglycerides
to di- and monoglycerides and into free fatty acids to be absorbed by enterocytes
(Mukherjee, 2003). Inhibition of pancreatic lipase reduces the efficiency of fat
absorption in the small intestine and thereby initiates modest long-term reduction in
body weight (Birari & Bhutani, 2007). Several anti-obesity agents derived from plant
phytochemicals have been identified for their potential to inhibit lipase activity (Nehir
& Simsek, 2012).
The effect of camel whey protein hydrolysates on porcine pancreatic lipase was
investigated in vitro for the first time in this study. As shown in Figure 12, all
hydrolysates showed a significant improvement in their lipase inhibitory activity
compared to the intact whey proteins. In a study conducted on Wistar rats, fermented
sardinelle protein hydrolysates (FSPHs) produced by proteolytic bacteria were orally
administered and found to reduce total cholesterol, triglycerides, and LDL-c serum
levels, increase in HDL-c and decrease pancreatic lipase activity (Jemil et al., 2017).
The authors concluded that FSPHs possessed bioactive peptides that could attenuate
hyperlipidemia and protect against cardiovascular disease in rats fed a high caloric
diet. Another study examined synthetic polypeptides of apolipoprotein C-III (apoCIII) and their effects on lipoprotein lipase inhibitory activity. Around 79% inhibition
of lipoprotein lipase was observed (McConathy et al., 1992). Results from this study
were similar in the manner that the peptides produced by enzymatic hydrolysis indeed
showed an enhanced lipase inhibitory effect; particularly efficient were the peptic
hydrolysates (Figure 12). An exceedingly small number of studies have investigated
the lipase inhibitory potential of milk bioactive peptides, thus more work needs to be
done to elucidate on the lipase inhibitory effects of such peptides. Overall, both
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cholesterol esterase and lipase inhibition activity were higher for CWPHs than
unhydrolyzed whey.
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Chapter 6: Conclusion
Camel milk as a source of bioactive peptides has gained interest in recent years.
It’s compositional and nutritional differences to that of bovine or caprine milk makes
camel milk a good candidate that can be investigated for potential additional benefits.
Although peptides with biological activities derived from camel milk and camel casein
protein have been reported previously (Salami et al., 2011; Badr, 2013; Jrad et al.,
2014a, 2014b; Kumar et al., 2016a; Tagliazucchi et al., 2016), there is a lack of data
available on camel milk whey proteins. Hence, the present study focused on producing
hydrolysates from camel whey protein using three digestive enzymes – pepsin, trypsin
and chymotrypsin, and assessing their potential bioactivities in vitro.
The results from this thesis clearly demonstrated that the camel whey proteins,
upon digestion with gastric (pepsin) and pancreatic (trypsin and chymotrypsin)
enzymes, exert potential antioxidative and antimicrobial effects, with chymotryptic
hydrolysates showing highest DPPH and ABTS radical scavenging activity, and peptic
hydrolysates displaying significant pathogen growth inhibition (%) activity,
respectively. ACE inhibitory properties were drastically increased upon hydrolysis
with all three enzymes, pepsin displaying a 4-fold increase. Anti-cholesterol activities
were demonstrated for the first time by the CWPHs wherein pepsin (6 h) generated
hydrolysates displayed highest lipase and cholesterol esterase inhibition activities.
Moreover, CWPHs inhibited enzymes like DPP-IV, α-glucosidase and α-amylase
which suggests potential anti-diabetic activities of camel milk whey proteins. Lastly,
the present study suggests that hydrolysis time may affect bioactivity of the
hydrolysates. In some experiments, longer hydrolysis improved the bioactivity, while
for some hydrolysates, the opposite was observed. This could be due to enzyme
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specificity, substrate degradation, and type of amino acid residues being released as
reported in earlier studies (Otte et al., 2007; Lacroix & Li-Chan., 2013; Kumar et al.,
2016b; Abd El-Fattah et al., 2017; Al-Shamsi et al., 2018). Overall, while intact camel
milk whey protein has already been identified for its in vivo therapeutic properties
owing to its content of lactoferrin, immunoglobulin and other active proteins, camel
milk whey proteins upon hydrolysis may exhibit multifunctional bioactive properties
in humans through a different mechanism of action.
The present study was mainly focused on screening the camel whey derived
protein hydrolysates for different bioactive properties by using three different enzymes
and different hydrolysis time. Although, the present study’s results are valuable,
however, they cannot be used to draw concrete conclusions on the bioactive potential
which CWPHs might display in the in vivo systems. This is because all experiments
were performed in vitro, and the hydrolysates may not necessarily exhibit the same
level of bioactivity in vivo or in cellular models. Thus, validation from animal or
human systems is critical since only in vivo studies can further elucidate on important
factors like nature, mechanism and bioavailability and reliably assess the bioactivity
of a given hydrolysate (FitzGerald et al., 2004; Vermeirssen et al., 2004).
Recommendations for future work include isolation, fractionation and identification
of bioactive peptides fragments in the hydrolysate demonstrating highest bioactive
properties. These studies could then pave way for incorporation of camel milk derived
bioactive peptides in functional foods at an industrial scale along with their potential
applications in the clinical management of chronic diseases like hypertension and
diabetes mellitus.
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